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Zinc is a ubiquitous biological metal in all 
living organisms. The spatiotemporal zinc 
dynamics in cells provide crucial cellular 
signaling opportunities, but also 
challenges intracellular zinc homeostasis 
with broad disease implications. Zinc 
transporters play a central role in 
regulating cellular zinc balance and 
subcellular zinc distributions. The 
discoveries of two complementary families 
of mammalian zinc transporters (ZnTs and 
ZIPs) in the mid-1990s spurred much 
speculation on their metal selectivity and 
cellular functions. After two decades of 
research, we have arrived at a biochemical 
description of zinc transport. However, in 
vitro functions are fundamentally different 
from those in living cells, where 
mammalian zinc transporters are directed 
to specific subcellular locations, engaged 
in dedicated macromolecular machineries 
and connected with diverse cellular 
processes. Hence, the molecular functions 
of individual zinc transporters are 
reshaped and deeply integrated in cells to 
promote the utilization of zinc chemistry to 
perform enzymatic reactions, tune cellular 
responsiveness to pathophysiologic 
signals and safeguard cellular 
homeostasis. At present, the underlying 
mechanisms driving the functional 
integration of mammalian zinc 
transporters are largely unknown.  This 
knowledge gap has motivated a shift of the 
research focus from in vitro studies of 
purified zinc transporters to in cell studies 
of mammalian zinc transporters in the 
context of their subcellular locations and 
protein interactions. In this review, we will 
outline how knowledge of zinc 
transporters has been accumulated from 
in-test-tube to in-cell studies, highlighting 
new insights and paradigm shifts in our 
understanding of the molecular and 
cellular basis of mammalian zinc 
transporter functions. 
 
Zinc is a defining feature of eukaryotic 
proteomes, populating in zinc-binding proteins 
that are encoded by ~10% of the human 
genome (1,2). While zinc is fundamental to 
eukaryotic cellular biology, it is a later addition 
to proteomes after the advent of a 
geochemical shift of an ancient high-sulfide 
ocean to the modern oxidizing, sulfate-rich 
one (3,4). The release of the sulfide-bound 
zinc provided zinc bioavailability to prompt a 
burst in the innovation of protein structures like 
zinc fingers with consequences for quickening 
the rise and diversification of eukaryotes in 
evolution (5). However, zinc utilization in 
eukaryotes came at the expense of increasing 
risk for interference with pre-existing cellular 
machineries evolved earlier. Accordingly, the 
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human body harnesses potentially toxic zinc 
chemistry in a spatially confined manner to 
avoid cytotoxicity. At the organ level, zinc is 
highly enriched in the hippocampus and 
neocortex region of the brain, prostate gland, 
and islets of Langerhans of the pancreas (6). 
These tissues accumulate abundant zinc into 
secretory pathways and release the stored 
zinc on demand. At the cellular level, the total 
cellular zinc content is submillimolar with 
uneven distributions ranging from a picomolar 
range of free cytosolic zinc to over 20 mM in 
specialized secretory vesicles (7-11). For 
example, zinc is highly enriched in pancreatic β-cells for insulin packaging, prostate 
epithelial cells for citrate production, and 
mammary epithelial cells for lactation (12). At 
the protein level, zinc transporters selectively 
capture and transport zinc ions across the 
membrane barriers to control zinc gradients 
across various biological membranes. 
Mammalian zinc transporters belong to two 
complementary protein  families (13):  the Zinc 
Transporter (ZnT) (14) and Zrt, Irt-like Protein 
(ZIP) (15). Ten ZnT and fourteen ZIP 
homologs are encoded by SLC30A1-10 and 
SLC39A1-14 genes in humans, respectively 
(13). Common to all zinc transporters is the 
ability of selective zinc binding, but bound zinc 
ions in ZnTs and ZIPs are transported in 
opposite directions. ZnTs are efflux 
transporters responsible for removing excess 
zinc in the cytoplasm whereas ZIPs are uptake 
transporters that replenish cytosolic zinc (Fig. 
1 A-C). The complementary functions of ZnTs 
and ZIPs stabilize the cytosolic zinc 
concentration around a homeostatic setpoint 
while enriching zinc in the lumen of specific 
subcellular compartments to support zinc-
dependent cellular processes.  
 
The multisite localizations of zinc transporters 
in mammalian cells increase the number of 
protein-protein interactions that drive 
functional crosstalks between zinc 
transporters and an array of cellular 
machineries performing diverse cellular 
processes beyond zinc transport. Hence, 
mammalian zinc transporters are organized in 
a functional hierarchy across scales — from 
the fundamental chemistry of protein 
structures through subcellular localizations 
and macromolecular complexes up to cellular 
processes that constitute the molecular 
physiology of mammalian cells. Accordingly, 
this review will begin with in-test-tube studies 
of isolated zinc transporters to illuminate how 
zinc coordination and geometric 
arrangements of binding residues confer zinc 
selectivity in protein structures, and how zinc 
bindings drive protein structural dynamics to 
move zinc up or down zinc concentration 
gradients across the membrane. In-cell 
studies of zinc transporters further showcases 
how zinc transporters are directed to distinct 
subcellular locations and engaged in different 
protein complexes in response to 
environmental stimuli. The next level of 
functional integrations takes place in zinc-
dependent biological processes in which 
individual zinc transporters coordinate 
networks of protein-protein interactions 
involved in cellular zinc signaling, ER 
homeostasis and unfolded protein response, 
and activation of zinc ectoenzymes in the early 
secretory pathway. The involvements of 
mammalian zinc transporters in diverse 
cellular processes provide insights into their 
global functions in human pathophysiology. 
Finally, we will summarize existing knowledge 
of loss-of-function (LOF) mutations and 
polymorphisms in human ZnTs and ZIPs, and 
their clinical manifestations in major human 
diseases.   
Zinc selectivity and its structural basis 
Cells acquire a variety of transition elements 
including iron, zinc, copper, manganese, 
cobalt, nickel, molybdenum, tungsten, 
chromium, and vanadium. These biological 
metals may exist in tightly bound forms such 
as metal-bound cofactors and proteins or 
nucleic-acid bound species, or loosely bound 
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forms in association with a diverse 
heterogeneous buffer. Biomolecules in the 
intracellular milieu have an extraordinary 
metal chelation capacity, probably containing 
an excess of high affinity binding sites relative 
to the number of transition metal ions in cells 
(16). According to the Irving-Williams series 
for the binding stability of divalent metal ions 
(17), zinc and copper would form the most 
stable complexes, preferentially accumulating 
in complexes with biomolecules if metal ions 
are presented in equal amounts in the test 
tube. However, in living organisms, metal ions 
are selectively acquired in cells, where metal 
transporters override the intrinsic 
thermodynamic propensity by the selection 
and compartmentalization of metal ions to 
enable metal-specific cellular processes. As 
such, the metal selectivity of zinc transporters 
is an essential aspect of cell biology, 
regulating the composition of the intracellular 
metallome and safeguarding the fidelity of zinc 
delivery to the right subcellular compartments 
in the right amount. While ZnTs and ZIPs 
transport zinc ions in opposite directions by 
different transport mechanisms, common to 
these zinc transporters is an overall metal 
selectivity for zinc. This raises the question as 
to how different zinc transporters exploit zinc 
coordination chemistry to select zinc against 
other similar metal ions.  
 
Zinc has an unusual electron configuration of 
[Ar]3d10. The completely filled d-orbital 
renders zinc redox-inert, and its ionic form has 
a fixed valence state of +2. Zinc is considered 
as a borderline soft-hard metal, being 
coordinated by both the sulfur atom of cysteine 
and nitrogen atom of histidine (soft base 
ligands), or by carboxylate oxygen atoms of 
aspartate and glutamate (hard base ligands) 
(18). Often, water molecules participate in zinc 
coordination and stabilize zinc ligation in 
particular conformations. In some cases, the 
binding of a water molecule to a positively 
charged zinc center reduces the pKa of water 
from 15.7 to ∼7, generating a hydroxide ion as 
a catalytically active species (19). A zinc ion 
with its filled d subshell has a marked 
preference for tetrahedral coordination 
geometry (20) dictated by the 18-electron rule 
(21). In addition, penta- and hexa-coordinated 
Zn(II) are frequently found in metalloenzymes 
with bound inhibitors or solvent molecules 
(20). The coordination geometry of each zinc 
binding site is broadly categorized by 
coordination number (N) and bond angles into 
tetrahedral (N=4), trigonal bipyramidal (N=5), 
and octahedral geometries (N=6). Despite the 
variability in zinc coordination environments, 
the affinity toward Zn(II) is usually high in the 
μM to pM range in diverse zinc metalloproteins 
(22,23). 
 
Zinc transporters are metalloproteins 
specialized for selective capture and vectorial 
movements of zinc ions across the membrane 
barrier. In this two-step molecular process, 
chemical properties of Zn(II) dictate the 
composition and geometry of metal-binding 
sites and their immediate surroundings to 
afford zinc selectivity. ZnTs and ZIPs are 
ubiquitous metal efflux and uptake 
transporters found in bacteria, archaea and 
eukaryotes (14,24,25). At present, bacterial 
zinc transporters, YiiP and ZIPB, are two 
representative ZnT and ZIP homologs for 
which crystal structures have been 
determined with bound Zn(II) and/or its 
isomorphous Cd(II) (Fig. 2A-B). The metal 
selectivities of YiiP and ZIPB have also been 
explicitly determined, providing the 
experimental basis for correlating metal 
selectivity with binding site composition and 
coordination geometry.  
 
YiiP is an integral membrane protein found in 
the cytoplasmic membrane of E. coli (26). It 
belongs to the protein family of cation diffusion 
facilitator (CDF) including mammalian ZnT 
homologs (27). YiiP was initially thought to be 
a ferrous iron transporter based on the effects 
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of its deletion or trans-expression on bacterial 
growth and survival (28). However, the 
presence of redundant metal transport 
systems and compensatory metal 
homeostatic controls could lead to 
misinformation on metal selectivity. A more 
rigorous determination of metal selectivity was 
developed using direct measurements of 
metal uptake into proteoliposomes mediated 
by purified and reconstituted YiiP proteins. 
The spectrum of YiiP metal substrates was 
profiled by inductively coupled plasma mass 
spectrometry (ICP-MS), showing that YiiP 
transported Zn(II) and Cd(II), but rejected all 
other transition metal ions in the fourth period 
(29). This selectivity profile for the purified YiiP 
in the test tube is identical to that of a single-
cysteine YiiP mutant in the native E. coli 
plasma membrane (30).  
 
ZIPB is a structural genomic target selected 
from a large collection of microbial ZIP 
homologs. It was found in B. bronchiseptica, 
thereby termed ZIPB (31). ICP-MS analysis of 
ZIPB in reconstituted proteoliposomes 
provided direct evidence that ZIPB transports 
Zn(II) and Cd(II), but rejects Fe(II), Cu(II), 
Co(II), Mn(II) and Ni(II) (31). Thus, ZIPB 
shares a common metal selectivity with YiiP. 
Zinc and cadmium are two group-12 d-block 
metals in the fourth and fifth period, 
respectively. They have similar outer electron 
configurations but vary in their ionic radii. It 
appears that common features in the electron 
configurations of Zn(II) and Cd(II) are 
exploited to confer Zn(II)/Cd(II) selectivity 
against transition metal ions with different 
preference for coordination number and 
geometry. On the other hand, the 
accommodation of distinct ionic sizes from 
0.74 Å for Zn(II) to 0.97 Å for Cd(II) 
demonstrates considerable fluidity in size 
selection, making a critical distinction from the 
size-based selectivity mechanism used by ion 
channels to discriminate s-block metals, such 
as potassium and sodium ion (32). 
The YiiP crystal structure revealed a Y-
shaped dimeric architecture arranged around 
a two-fold axis oriented perpendicular to the 
membrane plane (33,34) (Fig. 2A). A cryo-
EM structure of YiiP from S. oneidensis 
revealed a distinct inward-facing 
conformation in the lipid environment (35,36) 
(Fig. 2C). Each protomer comprises an N-
terminal transmembrane domain (TMD) 
followed by a C-terminal domain (CTD) that 
protrudes into the cytoplasm. Three distinct 
zinc binding sites were found in each 
protomer. The intramembranous site, also 
known as the transport-site, is localized to the 
hydrophobic core of TMD and responsible for 
Zn(II)/Cd(II) selectivity (30). Sidechains of 
four highly conserved residues (D49, D53, 
H153 and D157) are projected from two anti-
parallel transmembrane helices (TM2 and 
TM5) to form a classic tetrahedral 
Zn(II)/Cd(II) binding site (Fig. 2A). Metal 
binding analysis by isothermal titration 
calorimetry revealed a sub-µM range of 
Zn(II)/Cd(II) binding affinity (30,37). The 
binding reaction was coupled to the release 
of 1.23 proton upon each Cd(II) binding, 
suggesting a 1:1 Cd(II)-for-proton exchange 
(37). H153 in the tetrahedral transport-site is 
the sole proton-titratable residue under the 
physiological pH range. This residue may act 
as a proton donor or acceptor depending on 
Cd(II) coordination.  
 
The structure of ZIPB showed a monomeric 
transport unit consisting of eight 
transmembrane helices (TMs) forming a 
single helix bundle where the first four TMs 
(TM1 to TM4) are approximately two-fold 
related to the last four TMs (TM5 to TM8) (38) 
(Fig. 2B). These TMs intertwine to embrace a 
central binuclear metal center within an inner 
four-helix bundle stabilized by four peripheral 
TMs and lipid molecules that fill the inter-TM 
gaps. The binuclear metal center is situated in 
the hydrophobic core, likely responsible for 
Zn(II)/Cd(II) selectivity. ZIPB was co-
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crystallized with Cd(II) and its structure was 
solved with or without Zn(II) back soaking to 
partially replace bound Cd(II), yielding two 
conformations of the binuclear metal center 
occupied by either two Cd(II) or a Cd(II) and a 
Zn(II) (38). The metal ions trapped in the 
binuclear metal center are termed M1 and M2, 
respectively. They are bridged by one or two 
carboxylate residues (E181 or E181+E211) 
that form bidentate coordination (Fig. 2B).  M1 
is penta-coordinated while M2 is hexa-
coordinated. Their coordination spheres are 
primarily filled by ligands from residues 
located within two conserved hexapeptides: 
“177HNhPEG182” and “207QD/NhPEG212” (h 
refers to a hydrophobic residue) in TM4 and 
TM5, respectively. These TMs are kinked by 
P180 and P210 to properly place multiple 
ligating residues. Thus, the binuclear metal 
center is largely nested between TM4 and 
TM5, but residues from neighboring TMs, 
such as M99 from TM2 and E239 from TM6, 
fill up the coordination sphere. Of note, two 
coordination sites of M1 and one coordination 
site of M2 can be occupied by water molecules 
(38). These coordinated water ligands may 
exist as hydroxide ions to stabilize two closely 
associated metal ions within 4.5-Å in a low 
dielectric-constant environment of the inner 
membrane.   
 
The crystal structures of YiiP and ZIPB show 
that zinc coordination chemistry is richly 
exploited in different coordination spheres 
from a classical tetrahedral site to a more 
complex binuclear site with coordination 
numbers ranging from 4 to 6. Carboxylate 
anions of aspartate and glutamate are 
predominantly employed in the zinc transport 
sites of YiiP and ZIPB (Fig. 1C). The binding 
of a carboxylate residue offers two alternative 
binding modes between monodentate and 
bidentate coordination. A carboxylate can also 
form coordination bonds with two separate 
metal ions as a bridging residue. The ability of 
the carboxylate group to rearrange 
coordinating ligands gives high flexibility of the 
zinc coordination sphere while maintaining a 
constant coordination number (39). As such, 
Zn(II) and Cd(II) may be accommodated by 
virtue of  their shared preference for common 
coordination numbers and geometries, 
despite a large difference in their ionic radii. 
Although histidine is the most common 
coordinating residue in zinc enzymes (40), it 
occurs less frequently in transport-sites. 
Nevertheless, histidine plays a critical role in 
regulating proton-coupled or pH-dependent 
zinc transport as either a proton donor or 
acceptor. Cysteine is another prevalent 
coordinating residue in structural sites of many 
zinc metalloproteins (41), however, it is 
conspicuously missing in the transport-sites of 
YiiP and ZIPB.    
 
Structure guided discovery of functional 
mutations in zinc transport-sites provides 
insights into the roles of individual 
coordinating residues. The tetrahedral 
transport site of YiiP is highly conserved, and 
alanine substitutions to one of the residue 
quartets resulted in loss of both zinc binding 
and transport activity in YiiP and mammalian 
ZnT homologs (30,42). Thus, individual 
coordinating residues in the tetrahedral 
transport site are functionally important. 
Moreover, YiiP has a DDHD quartet for 
transporting both Zn(II) and Cd(II) whereas 
mammalian ZnTs have a HDHD quartet (27), 
selectively transporting Zn(II) only. A single H-
to-D substitution raised the thermodynamic 
barrier to Cd(II) binding, giving rise to a refined 
Zn(II) selectivity over Cd(II) in mammalian 
ZnTs (29). This finding demonstrates 
tuneability of metal selection by altering the 
residue composition of the tetrahedral 
transport-site. However, the residue 
composition of the tetrahedral site is still 
insufficient to predict metal selectivity of the 
CDF family members due to potential second 
shell interactions (41).  Other noted variations 
to the tetrahedral site are composed mainly of 
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Asn and Asp with additional Asn and Asp 
residues in the immediate surroundings. Such 
modified transport-sites in ZnT10 and a few 
bacterial homologs are responsible for 
selective Mn(II) transport (43-46). The 
switching of Zn(II) selectivity to Mn(II) is 
attributed to a preferential Mn(II) binding to 
Asp and Asn residues in an octahedral 
coordination geometry (41).  
 
In contrast to essential roles of individual 
coordinating residues in the tetrahedral 
transport-site of YiiP, individual residues 
participating in the binuclear metal center in 
ZIPB are functionally dispensable (47). 
Comparing multiple ZIPB crystal structures 
with variations in the binuclear metal center 
reveals two critical clues.  First, M1 
coordination is fluidic with alternative 
coordinating residues and water molecules: 
H177, E181, Q207, E211 and M99 when M1 
is a Cd(II), and E181, Q207, E211, and two 
water molecules when M1 is a Zn(II) (38). 
Thus, the loss of a coordinating group by a 
single alanine substitution could be 
compensated by the recruitment of an 
alternative coordinating residue or water 
molecule. Second, M2 coordination is neither 
required for zinc transport nor M1 binding (47). 
Ablation of the M2 site by triple alanine 
substitutions yielded a mutant crystal structure 
with no M2 binding, but a nearly identical wild-
type ZIPB conformation (47). The absence of 
M2 binding did not significantly alter the M1 
position and its coordination sphere. 
Moreover, single M1 binding occurs naturally 
in some ZIP homologs. For example, M2 in 
mammalian ZIP2 is occupied by a neighboring 
lysine residue (48).  
 
Functional characterization of the binuclear 
metal center in mammalian ZIP4 showed that 
the M1 site is essential to Zn(II) transport 
whereas the M2 site is auxiliary (47). The 
asymmetric functions of M1 and M2 sites 
reflect clustering of conserved residues 
around the M1 site while large residue 
variations around the M2 site may diversify 
binding properties of the binuclear metal 
center through M1-M2 interactions to 
influence the primary transport-site at M1 (49). 
The overall ZIP structure is evolutionally 
conserved from bacteria to humans, as 
demonstrated by a close alignment between 
the bacterial ZIPB crystal structure and a 
human ZIP4 structural model generated by co-
evolution-based contact prediction (50). 
Nearly all ZIP homologs have at least one 
carboxylate residue in the TM4 and/or TM5 
signature motif, allowing two metal ions to be 
bridged by one or two carboxylate groups. 
Within this conserved structural framework, 
variable protein sequences, local structural 
dynamics and incoming water molecules are 
expected to create far more fluidic 
coordination environments in ZIPs than a 
single tetrahedral transport-site in ZnTs. 
Existing metal transport data on mammalian 
ZIPs suggest promiscuous metal selectivity. 
For example, ZIP8 and ZIP14 are broad-
spectrum metal transporters that mediate 
cellular uptake of Zn(II), Fe(II), Mn(II) and 
Cd(II) (51,52). A glutamic acid residue was 
found in place of a highly conserved histidine 
residue in the predicted binuclear metal 
center. This E-to-H substitution may contribute 
to a shift of metal selectivity away from zinc 
(53). ZIP4 also exhibits polyspecific binding 
and transport of Zn(II), Cu(II) and possibly 
Ni(II) at higher concentrations (54). High-
resolution structures of metal-ZIP complexes 
and accurate experimental profiling of metal 
substrates are needed to unravel further the 
structural elements of metal selectivity in 
mammalian ZIPs.   
 
Dynamic mechanisms driving zinc mobility 
Zinc complexations that obey the 18-electron 
rule are typically "exchange inert". However, 
zinc bindings to zinc transporters are directly 
coupled to translocation across the membrane 
barrier. The mobility of zinc ions makes a 
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fundamental distinction between zinc 
transporters and zinc metalloenzymes, where, 
in the latter, zinc is generally considered as a 
permanent constituent of catalytic sites (23). 
Zinc movement in transporter proteins is an 
energetic process driven by transmembrane 
electrochemical gradients. A general form of 
free energy is stored in a proton gradient as an 
energy reservoir. It drives many secondary 
transport systems associated with nutrient 
uptake and maintenance of ionic homeostasis. 
YiiP transports zinc against its concentration 
gradient when the membrane becomes 
energized with a proton gradient.  In contrast, 
ZIPB transports zinc in an opposite direction, 
down a zinc concentration gradient (31). 
Hence, distinct mechanisms of zinc transport 
are expected to couple selective Zn(II) binding 
to either a proton motive force or a zinc 
concentration gradient to dislodge bound zinc 
ions from their coordination spheres to render 
mobility.    
 
In-cell characterization of individual zinc 
transporters is often hampered by the 
presence of redundant zinc transport systems, 
fluctuations of the proton motive force and zinc 
concentration gradient. A more direct kinetic 
analysis of zinc transport was developed using 
purified proteins in proteoliposomes 
encapsulated with a zinc-sensing fluorescent 
dye. The initial rate of zinc influx can be 
measured on a stopped-flow apparatus before 
the buildup of a significant intra-
proteoliposome zinc concertation. This in-test-
tube transport assay allows precise 
manipulations of proton and zinc gradients 
while a tight seal of the proteoliposome 
membrane enables robust measurements of 
zinc flux with a time resolution down to 5-10 
milliseconds. Stopped-flow kinetic analyses of 
YiiP and a second E. coli CDF protein, ZitB, 
revealed a substrate saturable transport 
process that can be fitted by the Michaelis-
Menten equation (30,55). This kinetic behavior 
indicates a two-step process initiated by a 
Zn(II)/Cd(II) binding followed by a protein 
conformational change to move the bound 
metal ion across the membrane. Zn(II)/Cd(II) 
binding rapidly reaches a steady-state while 
the ensuing conformational change 
constitutes a rate limiting step of the transport 
reaction (30,55). In an experimental setting 
with a Cd(II) concentration in equilibrium 
across the membrane, the stopped-flow 
application of a proton concentration jump 
caused a Cd(II) flux in opposition to the 
imposed proton gradient whereas depleting 
protons in the reaction buffer completely 
stalled Cd(II) transport despite an imposition 
of a Cd(II) gradient (55). These results clearly 
demonstrated an obligatory proton-coupled 
antiport mechanism. The Cd(II)-for-proton 
exchange stoichiometry was found to be 1:1 
by stopped-flow flux analysis, in agreement 
with the calorimetric titration result as 
described above (30,55). Hence, the observed 
Michaelis-Menten transport kinetics can be 
explained by a single-site, alternating-access 
model (56), in agreement with the observation 
of a single tetrahedral transport-site in the 
crystal structure of YiiP (33,34).   
 
The intramembranous transport-site in YiiP is 
situated in a hydrophobic environment lacking 
any pH titratable residue in its immediate 
surrounding (33,34). Thus, direct water 
access to the transport site is expected to act 
as a proton donor or acceptor to drive an 
obligatory zinc-for-proton exchange. The zinc-
driven proton transport could be probed by 
microsecond X-ray irradiation to activate water 
molecules in the zinc translocation pathway 
where residues in close proximity to the 
passing water molecules are covalently 
labeled by hydroxyl radicals and identified by 
bottom-up mass spectrometry (57,58). Zinc 
binding to YiiP was found to trigger a localized, 
all-or-none change of water accessibility to the 
transport-site and an adjacent hydrophobic 
gate at residue L152 (59). Millisecond time-
resolved dynamics revealed that zinc binding 
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to the transport-site drove a rapid TM5 motion 
coupled to the gating of L152, resulting in 
alternate exposures of the transport-site to two 
solvent-filled cavities on either side of the 
membrane. The in-cell transmembrane proton 
gradient of E. coli is about one to two pH units 
around the expected pKa of H153 in the 
transport-site (60). The flipping of H153 as a 
part of the transport-site to either side of the 
membrane is expected to change its 
protonation state (Fig. 2C). A deprotonated 
H153 facing a relatively alkaline cytosol would 
promote zinc binding from the intracellular 
cavity whereas a protonated H153 facing a 
relatively acidic periplasm may facilitate zinc 
release into the extracellular cavity. As such, 
an inward pH gradient drives a vectorial zinc 
efflux in a 1:1 exchange stoichiometry. In this 
process, protonation and deprotonation of 
H153 are mediated by water access through 
the adjacent L152 that is directly coupled to 
zinc binding to the transport-site. 
Consequently, the gated water access to the 
transport-site enables a stationary proton 
gradient to facilitate the conversion of the 
proton potential energy to the kinetic power 
stroke of a vectorial zinc transport (59). 
 
Contrary to a single tetrahedral transport-site 
and a complete lack of outer shell interactions 
in YiiP, the crystal structure of ZIPB revealed 
multiple metal coordination sites characterized 
by fluidic coordination environments and 
participations of coordinating water molecules 
that are stabilized by residues in the second 
coordination sphere (38). These structural 
features suggest a transport mechanism 
distinct from the single-site alternating-access 
model. Indeed, stopped-flow kinetic analysis 
of  purified ZIPB in proteoliposomes showed 
that ZIPB-mediated zinc flux is nonsaturable, 
electrogenic and voltage dependent (31). 
Although ZIPB activity is pH dependent, ZIPB-
mediated zinc transport is not coupled to the 
proton motive force (31). Instead, the zinc 
equilibrium potential exhibits a Nernst 
relationship predicted for the divalent zinc ion 
while the voltage dependence of the zinc flux 
also follows the Goldman-Hodgkin-Katz 
current equation at a symmetrical zinc 
concentration. These data provide strong 
evidence that the ZIPB-mediated zinc flux is 
electrodiffusional through a zinc permeant 
channel (31). Similarly, human ZIP2 was 
found to function independent of the proton 
motive force, but was modulated by the 
extracellular pH and membrane potential (61). 
Of note, the zinc flux through ZIPB is 
extremely slow in comparison to the 
potassium ion flux through potassium 
channels. The restricted zinc flow implies 
highly constrained zinc bindings that limit 
Zn(II) mobility along a transmembrane 
conduit. This kinetic behavior is consistent 
with the binuclear metal bindings in the ZIPB 
crystal structure. All bacterial ZIPs identified 
thus far promote zinc influx into the cytoplasm 
where zinc is buffered to extremely low levels 
around homeostatic set points (62). From an 
energetic standpoint, ZIPB may provide a zinc 
conduit in the membrane barrier that allows 
zinc to flow into the cytoplasm down its 
concentration gradient.  
 
The zinc translocation pathway in ZIPB is 
distinctively different from that of YiiP due to 
the presence of a sequence of highly 
constrained zinc ions (38). These bound zinc 
ions are approximately aligned in a single file 
and also partially hydrated (Fig. 2D). Since 
ZIPB constitutes a major uptake route for 
bacterial zinc acquisition, a high zinc binding 
affinity is a prerequisite for effective zinc 
capture (63), but the high affinity may trap 
bound zinc ions to impede their 
transmembrane movement. The dynamic 
process of water access to the binuclear metal 
center revealed by X-ray footprinting uncovers 
an active role of hydration water molecules in 
releasing the trapped zinc ions (64). Contrary 
to the expectation that zinc binding would 
block water access as observed in YiiP, 
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multiple zinc bindings in ZIPB were 
concomitant with increased water accessibility 
to selective coordinating residues, indicating 
that zinc ions and water molecules are co-
transported (64). In the intramembranous 
binuclear metal center, zinc coordination fully 
protected E181. This loss of water access is 
balanced by increased water access to the 
Q207-D208-E211 triad and E240 (64). The 
opposite changes in water accessibility 
suggest that water entry to subpockets of the 
binuclear metal center may partially rehydrate 
the bound zinc ions, switching the mode of 
coordination residues from zinc binding to 
release. Mapping water-reactive residues to 
the ZIPB crystal structure revealed a water 
translocation pathway that overlapped with a 
zinc translocation pathway defined by X-ray 
crystallography (38,64). Following the 
intramembranous binuclear metal center, zinc 
ions navigate through the translocation 
pathway via an interim zinc binding site to a 
peripheral binuclear metal center at the 
cytoplasmic exit (38). These binding sites are 
closely spaced, allowing a series of ligand 
exchanges between consecutive binding sites 
to relay a bound zinc ion from one binding site 
to another down a zinc concentration gradient 
(65). The peripheral binuclear metal center is 
thought to form a high-affinity sink to hold 
imported zinc before the bound zinc is 
accepted by cytosolic zinc-binding proteins 
such as metallochaperones, although zinc-
specific metallochaperones have yet to be  
identified (66,67). This diffusional mechanism 
was similarly ascribed to the copper uptake 
transport Ctr1 where Cu+ diffusion is mediated 
by consecutive Cu+ binding sites, leading 
toward a high-affinity copper sink at the 
cytoplasmic exit (68).  
 
Comparative structural analyses provide further 
insights into how protein conformational 
changes or local structural dynamics achieve 
differentiated functions of zinc transport in YiiP 
and ZIPB. Comparing X-ray and cryo-EM 
structures of YiiP homologs revealed large 
conformational changes between an inward- 
and outward-facing conformation, providing 
direct evidence for the alternating-access 
mechanism (35). A major conformational 
change involves pivoting of a four-helix bundle 
(TM1, TM2, TM4 and TM5) relative to a TM3-
TM6 helix pair to flip over the zinc accessibility 
to either side of the membrane while a minor 
conformational change involves twisting of TM2 
and TM5 in the four-helix bundle (35,36). Since 
the transport-site is confined exclusively 
between TM2 and TM5 (34), a small TM2-TM5 
shift could lead to a large readjustment of the 
zinc-coordination geometry either in favor of 
zinc binding or release, thereby allowing for 
allosteric regulation of zinc coordination through 
protein conformational changes (34). As a 
result, the zinc turnover rate of YiiP is several 
orders of magnitudes faster than zinc exchange 
rates in typical zinc metalloproteins. 
 
By comparison, no significant conformational 
change was observed among ZIPB crystal 
structures when bound metal ions were partially 
released by soaking crystals in a metal-free 
buffer or when metal binding to the M2 site of 
the binuclear metal center was ablated by triple 
point mutations (47). The findings of partially 
hydrated Zn(II)/Cd(II) in ZIPB crystal structures 
provides a critical clue as to the dynamic 
mechanism driving zinc movements. Multiple 
crystallographic water molecules were found in 
the hydration shells of bound metal ions, and 
also in close proximities to protein ligands that 
participated in binuclear metal coordination. 
Positional shifts of coordinating residues via 
local conformational dynamics would suffice to 
switch interactions from a bound metal ion to 
solvation water molecule, favoring zinc release 
over binding. This notion is supported by 
comparative X-ray footprinting analyses of ZIPB 
with and without zinc binding (64). The 
reciprocal pattern of water accessibility changes 
in both binuclear metal centers and their 
associations with vicinal crystallographic water 
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molecules provide clear structural evidence for 
direct water access to a sequence of five zinc 
binding sites in ZIPB (64). In sharp contrast, a 
single tetrahedral transport-site in YiiP (33) was 
completely protected from water access by zinc 
binding (59). Hence, accumulating data support 
a transport model in which water dynamics 
complements metal coordination chemistry to 
confer mobility to trapped zinc ions in ZIPB, 
highlighting the functional importance of 
solvated water in driving zinc transmembrane 
diffusion. 
 
Bacterial YiiP and ZIPB serve as prototypes for 
mammalian ZnTs and ZIPs, respectively. 
Detailed structure-function studies lay the 
foundation for understanding the inner workings 
of mammalian ZnTs and ZIPs as to how 
coordination chemistry is built into different 
protein structures to confer zinc selectivity, but 
with distinct mechanisms driving zinc mobility. 
The tetrahedral transport-site in YiiP is highly 
conserved from bacteria to humans. It is likely 
that mammalian ZnTs harness the proton 
motive force to actively pump zinc by 
conformational changes that alternatively 
expose a single transport-site to either side of 
the membrane surfaces (59). Indeed, a recent 
cryo-EM structure of human ZnT8 validated a 
conserved tetrahedral transport site, which  is 
alternately accessible to zinc binding from either 
side of the membrane during the zinc transport 
cycle (69). Interestingly, human ZnT8 in the 
absence of zinc binding to the transport-site 
exhibited heterogeneous dimeric conformations 
with one protomer in an inward-facing and the 
other in an outward-facing conformation. The 
conformational conversion between these two 
states involved rocking motions of TM1, TM2, 
TM4, and TM5 relative to the TM3-TM6 helix 
pair as described for YiiP. The modes of 
operation in TMD are similar between bacterial 
YiiP and human ZnT8, but differences were 
noted in zinc bindings to cytosolic domains. A 
mammalian-specific HCH motif at the N-
terminus of ZnT8 contributes to zinc 
coordination to the CTD of a neighboring 
subunit.  This HCH motif is also connected to 
the N-terminus of TM1, allowing cytosolic zinc 
binding to influence the stability and transport 
function of the TMD (69). On the other hand, the 
binuclear metal center in ZIPB is less conserved 
and individual coordinating residues are 
functionally dispensable. This raises a question 
as to whether a conserved electrodiffusion 
mechanism of zinc transport exists from 
bacteria to humans. In bacteria, ZIPB is 
responsible for zinc uptake as a micronutrient, 
facilitating passive diffusion of extracellular zinc 
into the cytoplasm down an inward zinc 
concentration gradient  (7). Likewise, the zinc 
level in human sera (>10 µM) is many orders of 
magnitude higher than the homeostatic set point 
of cytosolic free zinc concentrations in 
mammalian cells. This imposing zinc gradient is 
maintained by a multitude of mammalian zinc 
transporters and intracellular zinc buffering 
proteins. Up to now, in-cell measurements of 
zinc transport by various mammalian ZIPs have 
shown a consistent substrate saturable process 
with Michaelis-Menten steady-state kinetics 
(38,48,50,61). Such kinetic behaviors seem 
consistent with a single-site alternating-access 
model, but more rigorous functional studies of 
purified proteins in a well-defined experimental 
setting are required to unequivocally define the 
transport mechanism for mammalian ZIPs.  
 
Surfacing of zinc transporters in response 
to environmental stimuli While coordination 
chemistry and protein dynamics dictate 
selective binding and transport of zinc ions, 
compartmentalization of zinc transporters in 
mammalian cells provides the cellular context 
for the execution of transport functions and 
their integration into diverse cellular processes. 
The in-cell functions of individual mammalian 
zinc transporters are determined by their 
specific homes in various subcellular 
compartments and their specific molecular 
partners interlinked within the cellular protein 
network (interactome). Depending on the type 
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of cells and cellular environments, a zinc 
transporter could be trafficked to different 
subcellular destinations and engaged in 
different protein interactions. This raises two 
fundamental questions: how a specific zinc 
transporter is placed in the right subcellular 
location at the right time in the right amount, 
and how protein interactions couple zinc 
transporters to macromolecular machineries 
to influence cellular processes. At present, 
there is a paucity of biochemical data on 
localizations of individual zinc transporters, 
even less on the organization of the zinc 
transporter interactome and the dynamics of 
protein interactions in response to 
pathophysiological stimuli. We will use 
relatively well-studied examples of 
mammalian zinc transporters to illustrate the 
molecular mechanisms underlying in-cell 
functions. The existing knowledge is far from 
complete, but the granular data may help 
define knowledge gaps and take us towards a 
more complete understanding of the inner 
workings of mammalian zinc transporters. 
 
We begin with the regulation of zinc 
transporters on the surface membranes of 
enterocytes, which are intestinal absorptive 
cells lining the inner surface of the small 
intestine. Dietary zinc enters the polarized 
enterocytes through the apical membrane 
followed by zinc release into the circulation at 
the basolateral side. The trans-epithelial zinc 
movement is orchestrated by coordinated 
functions of many mammalian zinc 
transporters, including ZnT1, ZnT2, ZnT4, 
ZnT5, ZnT6, ZnT7, ZIP4, and ZIP5 (70). 
Among them, ZIP4 and ZnT1 are a pair of zinc 
uptake and efflux transporters localized to the 
apical and basolateral membrane, 
respectively (71,72). Their opposite directions 
of zinc transport and spatial segregation on 
different surface membranes allows them to 
play a major role in driving vectorial zinc 
movement from the intestinal lumen to the 
blood. Zinc fluxes across apical and 
basolateral membranes need to be balanced 
to maintain intracellular zinc homeostasis 
while the net trans-epithelial zinc flux is also 
regulated to maintain systemic zinc 
homeostasis in the face of dietary zinc 
fluctuations. As a result, the abundance of 
ZIP4 and ZnT1 on the respective cell surfaces 
is tightly regulated according to the zinc 
availability. Zinc-deficiency promotes 
accumulation of ZIP4 on the surface 
membrane (73-77). On the other hand, high 
extracellular zinc levels not only induce 
internalization of surfaced ZIP4, but also 
trigger drastic removal of cellular ZIP4 via 
proteasomal and lysosomal degradation 
pathways (77). Under normal culture 
conditions, ZIP4 is transcribed and 
continuously internalized to maintain a low 
level of cell surface expression  (77). Hence, 
zinc uptake by ZIP4 across the apical 
membrane is principally modulated by a 
putative zinc-dependent brake of ZIP4 
internalization. When the extracellular zinc 
level reaches a threshold, auxiliary structural 
components such as zinc sensors may be 
triggered to activate ZIP4 endocytosis by 
releasing the internalization brake. 
 
Three potential zinc sensing elements have 
been proposed in the human ZIP4 (hZIP4) 
sequence: a histidine-rich loop (His-rich) in a 
large N-terminal extracellular domain (ECD), a 
histidine-containing HxH motif in the 
extracellular loop between TM2 and TM3, and 
a His-rich cluster in the cytosolic loop between 
TM3 and TM4 (Fig. 3A). The His-rich loop in 
the ECD was shown to bind zinc with a low µM 
affinity (78,79), and the cytosolic His-rich 
cluster was shown to bind zinc with nanomolar 
affinity (80). However, direct evidence for a 
zinc sensing role is still missing because H-to-
S or G substitution mutations in these 
sequences caused no changes to zinc 
sensing of hZIP4 (81). Moreover, 
intramembranous zinc binding may play a 
critical role in zinc sensing in hZIP4. D-to-A 
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mutations to coordinating residues in the 
binuclear metal center abrogated zinc sensing 
(81). Zinc binding to the binuclear metal center 
may be allosterically coupled to the cytosolic 
loop between TM3 and TM4, which is 
associated with zinc-stimulated endocytosis. 
 
Most ZIPs are localized to the cell surface 
(52,82-88). Thus far, zinc-dependent 
endocytosis has been reported for ZIP1 and 
ZIP4. Generally, endocytosis needs specific 
motifs such as [DE]XXXL[LI] and tyrosine‐
based endocytosis signals (YXXØ), which 
operate at the binding site for membrane 
bound adaptor proteins (APs) (89,90). In 
hZIP4, a [DE]XXXL[LI]-like motif  is found in 
the cytosolic loop between TM3 and TM4, but 
substitutions of the two Leu residues  with Ala 
residues were insufficient to produce an effect 
on hZIP4 endocytosis (81). Instead, a 
conserved LQL motif in the same cytosolic 
loop acts as a critical determinant for hZIP4 
endocytosis (81). The conformational change 
triggered by zinc binding to the binuclear metal 
center may induce the LQL motif to fold into a 
conformation so that hZIP4 is recognizable by 
yet-to-be identified APs (81). This 
conformation-dependent endocytosis of hZIP4 
is proposed to occur constitutively in a 
ubiquitin-independent manner under normal 
conditions with adequate but non-excessive 
zinc. Interestingly, all plasma membrane 
located ZIPs in the LIV-1 sub-family have 
some forms of the LQL motif which fits the 
consensus motif [I,L,S]Q[L,N,D,P,A], 
suggestive of functional importance 
throughout the family. In addition to the LQL 
motif, the aforementioned cytosolic His-rich 
cluster in the TM3-TM4  loop is involved in 
zinc-stimulated ubiquitination and degradation 
of hZIP4 under excess zinc conditions (75). In 
ZIP1, a [DE]XXXL[LI]-like peptide in the 
cytosolic loop between TM3 and TM4 
mediates ZIP1 endocytosis (91,92). Because 
the cytosolic loops are divergent in the protein 
sequence, the number of His residues and the 
length among ZIP proteins (Fig. 3A), they may 
provide unique properties for each ZIP protein, 
including apical or basolateral sorting of ZIPs, 
in addition to the regulation of endocytosis. 
 
Zinc sensing and zinc-stimulated endocytosis 
of ZIP4 are slightly different between the 
human and mouse homologs. In mZIP4, the 
HxH motif in the extracellular TM2-TM3 loop is 
required for a high sensitivity of mZIP4 
endocytosis in response to low zinc 
concentrations (93). However, the HxH motif 
is not involved in zinc sensing in hZIP4 as 
discussed above.  mZIP4 is constitutively 
degraded following endocytosis in cells 
cultured in medium containing low µM zinc 
concentrations (77). In the small intestine of 
mouse and rat fed a diet with zinc, ZIP4 is 
hardly detected  (74,94). Detailed analyses of 
the mouse-human difference in the kinetics of 
endocytosis and degradation of ZIP4 are 
required to gain a more complete 
understanding of the regulated endocytosis of 
mammalian ZIP4 and their underlying 
mechanisms.    
 
ZIP4 surfacing is further regulated post-
translationally. The extracellular N-terminus of 
ZIP4 is proteolytically cleaved during a 
prolonged zinc deficiency (72,94). This 
process is endocytosis-dependent. The 
cleaved ZIP4, constituting all 8 TMs, can also 
accumulate on the cell surface, thus showing 
the dispensability of the N-terminus for ZIP4 
surfacing (72,79,93,94). Nevertheless, the N-
terminally cleaved ZIP4 is internalized at a 
faster rate than the full length ZIP4, suggesting 
that the extracellular N-terminal portion may 
be involved in regulation of the sensitivity to 
zinc-stimulated endocytosis in addition to zinc 
transport activity (93). Importantly, a similar N-
terminal cleavage has been observed with 
ZIP6 and ZIP10 (86,95), which are often 
involved in trafficking the active form of zinc 




In contrast to the surface expression of 
multiple zinc uptake transporters in the ZIP 
family, the only zinc efflux transporter 
predominantly targeted to the plasma 
membrane is ZnT1 in the mammalian ZnT 
family (43).  Surface expression of ZnT1 is 
critically important to reducing zinc toxicity by 
exporting excess cytosolic zinc into the 
extracellular space (96). The response of zinc-
dependent ZnT1 surfacing is opposite to that 
of ZIP4. Excess zinc exposure would increase 
ZnT1 surface expression as well as its total 
cellular expression mediated by transcriptional 
up-regulation under the control of metal 
response element binding transcription factor 
1 (MTF1) (71). Zinc deficiency reduces ZnT1 
surface expression, and the internalized ZnT1 
is further removed  through degradative 
pathways (71). When translation of ZnT1 was 
blocked by a protein synthesis inhibitor 
cycloheximide, ZnT1 was degraded much 
faster than tubulin under normal culture 
conditions. As discussed in ZIP4 endocytosis, 
it is still unclear which APs are involved in 
ZnT1 endocytosis under zinc-deficiency, and 
how high zinc exposure may suspend ZnT1 
endocytosis. Furthermore, post-translational 
modifications of ZnT1 regulate ZnT1 stability 
in a zinc-responsive manner. Loss of N-
glycosylation at Asn299 in an extracellular 
loop between TM5 and TM6 stabilized ZnT1, 
but it did not affect trafficking of ZnT1 to the 
cell surface. Interestingly, a similar stability 
control by N-glycosylation was found in ZIP14 
(94). N-glycosylation was also required for the 
iron sensitivity of ZIP14 surface expression 
(97).  
 
While ZnT1 and ZnT10 are respectively zinc 
and manganese efflux transporters targeted to 
the cell surface membrane, mammalian ZnTs 
generally are zinc sequestrating transporters 
localized to intracellular membrane 
compartments (Fig. 1A). Some ZnTs targeted 
to the secretory vesicles can be transiently 
trafficked to the surface membrane following 
exocytotic fusion of secretory vesicles with the 
surface membrane (98-100). In pancreatic β-
cells, glucose-stimulated insulin secretion is 
coupled with the surfacing of ZnT8, which may 
contribute to a cytosolic zinc surge following 
glucose exposure (99). In mammary gland 
epithelial cells, lactation hormones trigger 
surfacing of ZnT2 and ZnT4, the latter may be 
further facilitated by zinc exposure (101,102). 
This type of ZnT surfacing control is operative 
in secretory cells where a rapid recycling 
mechanism may be necessary to restore the 
localization of vesicular ZnTs.    
 
Functional diversification by multi-layers 
of protein interactions Protein interactions 
add another dimension of functional 
integration to mammalian zinc transporters in 
addition to subcellular trafficking, post-
translational regulation and tissue-specific 
expression. Protein interactions display a 
continuum of binding strength and stability 
(103). Many interactions are transient, and 
alternative interactions may occur in specific 
cellular contexts or at particular times during 
cell lineage specification. The dynamic 
organization of zinc transporter interactomes 
results in segregation of zinc transporters and 
functionally related proteins into 
interconnected protein communities 
corresponding to multi-protein complexes, 
subcellular protein co-localizations and 
intracellular signaling cascades (104). At the 
molecular level, individual zinc transporters 
are assembled into functional modules 
through homo- and hetero-oligomerization of 
monomeric ZnT and ZIP homologs. These 
functional modules are further assembled into 
protein networks dedicated to specific cellular 
processes. At present, architectures of zinc 
transporter interactomes are largely unknown 
with one exception (see below), but well-
studied examples of ZnT/ZIP interacting 
proteins provide a glimpse of context-specific 
organization of zinc transporter interactomes 
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that drive the integration of zinc transport 
activity to diverse in-cell functions. 
 
The first layer of protein interactions takes 
place among monomeric forms of ZnT and ZIP 
as the functional unit of zinc transport. Crystal 
structures of YiiP and ZIPB suggest that 
extramembranous domains may contain 
signals directing oligomerization. YiiP is 
purified as a stable homodimer (105), joined 
together mostly by two cytosolic C-terminal 
domains (CTD) with zinc bindings at the dimer 
interface (Fig. 2A) (34). Zinc binding 
strengthens the CTD-CTD association by 
neutralizing electronegative surfaces of two 
opposing CTDs (106). As such, the CTD of 
YiiP may act as a dimerization joint as well as 
a cytosolic zinc sensor. Zinc binding to the 
CTD interface triggers an inter-CTD motion, 
which  alters the coordination geometry of the 
transmembrane transport-site, thereby 
allosterically regulating its transport activity 
(34). Human ZnT8 contains two separate 
tetrahedral zinc binding sites at the CTD 
interface in positions similar to that of a 
binuclear zinc center in YiiP (69). The 
additional zinc coordinates in ZnT8 are 
provided by the HCH motif of NTD from a 
neighboring subunit to establish NTD-CTD 
interactions to allosterically regulate the TMD 
conformation as discussed above (69). In 
addition, dimerization of mammalian ZnTs 
could be mediated by inter-CTD dityrosine 
bonds. Covalent dimerization represents a 
novel mechanism regulating subcellular 
localization and zinc transport activity of 
mammalian ZnTs (107).  
 
ZIPB can exist in different oligomeric forms 
from monomer to homodimer (31,38) to 
higher-order polymerization as observed by 
cryo-EM imaging of purified ZIPB in detergent 
micelles. The crystal structure of ZIPB was 
determined in the lipid cubic phase with four 
outer TMs that create large gaps for lipid-filling 
on the monomer surface (38). Accordingly, 
delipidation of ZIPB by different detergent 
treatments influences the non-specific 
oligomeric association. Mammalian ZIPs are 
generally divided into four subfamilies, ZIPI, 
ZIPII, LIV-1, and gufA (Fig. 1B) (15,107). 
Among them, members of the LIV-1 subfamily 
have a large N-terminal extracellular domain 
(ECD), which can independently form 
homodimers in the absence of any TMs 
(79,87). A highly conserved motif, termed 
CPALLY, is present preceding the TM region 
in the members of the LIV-1 family that are 
targeted to the plasma membrane (Fig. 3) 
(53). This motif consists of the consensus 
sequence C[X26]CP[X4]Q[X5]C where X is 
any amino acid (108). Three conserved 
cysteine residues in this motif are presumably 
involved in disulphide bonds, which were 
observed between the first and last cysteine 
residues in ZIP4 (79). Furthermore, this motif 
is positioned at the ECD-ECD interface 
involved in dimerization. Indeed, LIV-1 
subfamily ZIPs with the motif, such as ZIP4, 
ZIP5, ZIP6 and ZIP10, form homodimers 
(86,109-111). Nevertheless, lacking the 
CPALLY motif did not prevent human ZIP7 
and ZIP3 from forming homodimers (112,113), 
suggesting that it may play additional roles 
other than dimerization. All LIV-1 family ZIPs 
contain multiple His-rich sequences, 
especially in the ECD and the cytosolic loop 
between TM 3 and TM4, as demonstrated by 
ZIP4, ZIP5, ZIP6, ZIP7 and ZIP10, where the 
total number of histidine residues can exceed 
50 (Fig. 3A). Zinc binding to the extracellular 
His-rich cluster was detected at a low µM 
affinity in ZIP4 as discussed above, while 
mutations to zinc binding sites and other 
conserved ECD sequences could significantly 
alter zinc transport (78,79). Hence, the ECD of 
ZIPs mirrors the CTD of ZnTs in monitoring 
zinc availability on either side of the 





While most ZnTs and ZIPs are thought to be 
functional as homodimers, heterodimerization 
occurs naturally among some members of the 
ZnT and ZIP protein family. A well-
characterized heterodimer is ZnT5-ZnT6 (114-
118), which is conserved in eukaryote cells 
including yeast and plants (119-123). The 
functional roles of ZnT5 and ZnT6 in a 
heterodimer are asymmetrical. ZnT5 contains 
a canonical tetrahedral zinc-transport site 
whereas ZnT6 misses two zinc-coordinating 
residues by hydrophobic residue substitutions. 
Thus, ZnT5 is thought to be an operative zinc 
transporter while ZnT6 a putative auxiliary 
protomer in the heterodimer (115). ZnT5 also 
appears to carry the sorting signal directing 
the ZnT5-ZnT6 heterodimer to the Golgi 
apparatus(124). ZnT5-ZnT6 
heterodimerization is likely mediated by CTD-
CTD interactions. This was demonstrated 
using chimeric ZnT7 whose CTD was 
swapped with that of ZnT5. The resultant 
chimera recapitulated ZnT5-like features, that 
is, formed heterodimers with ZnT6 (115). 
Moreover, sorting signals in individual ZnT 
monomers could be combined through 
heterodimerization to alter subcellular 
localizations of other ZnT homologs (125). 
When a pair of fluorescently-tagged ZnT 
homologs was transiently co-expressed in 
breast cancer MCF-7 cells, heterodimerization 
was detected by bimolecular fluorescence 
complementation (117). The resultant 
heterodimers were trafficked to altered 
subcellular locations intended for individual 
ZnTs (117). For example, ZnT1 was targeted 
to the plasma membrane in homodimers, but 
re-directed to intracellular vesicles when 
heterodimerized with ZnT3. In contrast, ZnT3 
dimerization was insufficient to re-direct ZnT2, 
ZnT4 and ZnT10 to synaptic vesicles in 
pheochromocytoma PC12 cells where ZnT3 
homodimers were destined to synaptic 
vesicles (125). On the other hand, ZnT2 and 
ZnT4 were re-localized to the plasma 
membrane when heterodimerized with ZnT1 
in MCF-7 cells (117), as opposed to their 
respective homodimer localizations to 
intracellular compartments (126,127). These 
findings revealed a network of ZnT homo- and 
heterodimers with distinct subcellular 
localizations, suggesting a potentially 
prevalent role of heterodimerization in 
regulating ZnT subcellular distribution. Further 
studies are needed to validate native ZnT 
heterodimers and their subcellular 
localizations in mammalian cells with 
endogenous ZnT expressions.    
 
Heterodimerization between endogenous 
ZIP6 and ZIP10 was identified in mouse 
mammary gland epithelial NMuMG cells 
based on in-situ proximity ligation analysis and 
immuno-precipitation proteomics with tandem 
mass tag labeling and bottom-up relative 
mass spectrometric quantification (87). 
Among mammalian ZIPs, ZIP6 and ZIP10 are 
the closest paralogues of the LIV-1 subfamily 
containing an N-terminal prion protein (PrP)-
like sequence within the ECDs. ZIP6 and 
ZIP10 can form respective homodimers 
targeted to the plasma membrane where they 
mediate cellular zinc uptake, which often 
triggers cells to undergo epithelial-to-
mesenchymal transition (EMT) 
(86,87,128,129), a process by which epithelial 
cells lose their cell-cell adhesion and gain 
migratory properties to become multipotent 
mesenchymal stem cells during embryonic 
development and tissue regeneration. 
Interestingly, ZIP6-ZIP10 heterodimers can 
also trigger mitosis, a process of cell division 
that requires cell rounding to be initiated (130). 
The full differences between these functional 
heterodimers are still unclear, as contributions 
of other ZIP transporters, such as ZIP5, have 
yet to be clarified. However, accumulating 
evidence suggests that ZIP6-ZIP10 
heterodimerization allows for functional 
moonlighting as a key regulator in cell 
morphogenetic programs (87). Since ECDs of 
mammalian ZIPs are not well conserved or 
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even missing in certain ZIP homologs, 
heterodimerization among ZIPs is thought to 
be limited to a subset of ZIPs carrying PrP-like 
sequences within the ECDs (95,131). These 
ZIPs form a separate clade of LIV-1 ZIPs 
comprising ZIP5, 6 and 10. 
Heterodimerization among members of other 
clades of the mammalian ZIP family has yet to 
be established.   
 
Zinc transporters greatly expand their protein 
interaction networks through a second layer of 
protein interactions involving higher-order 
heterocomplexes with proteins other than zinc 
transporters. In mammary gland epithelial 
cells, ZnT2 was found to directly interact with 
vacuolar proton-ATPase (V-ATPase), and 
such interactions are critical for V-ATPase 
assembly associated with secretory vesicle 
biogenesis, acidification and secretion (132). 
In cultured cardiomyocytes, ZnT1 interacted 
with the β-subunit of the L-type calcium 
channel (LTCC), inhibiting the trafficking of the 
LTCC α1-subunit to the surface membrane 
(133). In epidermal keratinocytes, ZnT1 was 
shown to form heterocomplexes with EVER1 
and EVER2 proteins encoded by genes 
associated with an inherited skin disorder, 
epidermodysplasia verruciformis. ZnT1-
EVER2 interactions altered the intracellular 
zinc distribution and inhibited a group of zinc-
dependent transcription factors (134). In both 
cases, ZnT1 was not sorted to its regular 
destination on the cell surface, but to 
intracellular compartments by forming 
heterocomplexes as retention scaffolds 
(133,134). In a Xenopus oocytes heterologous 
expression system, ZnT1 and its C. elegans 
homolog CDF1 were found to bind to a 
regulatory domain of the protein kinase Raf1, 
facilitating Raf-1 translocation to the plasma 
membrane where ZnT1-Raf1 interactions 
activated Raf1, leading to downstream 
activation of mitogen-activated protein kinase 
(MAPK) members ERK1 and ERK2 (135). The 
basal Raf1 activity was inhibited by cytosolic 
zinc binding, raising the possibilities that ZnT1 
upregulated Raf1 either directly via protein 
interactions or indirectly due to zinc efflux in 
close proximity to Raf1 in a ZnT1-Raf1 
complex. (135). Hence, accumulating data 
indicate that heterocomplex formation enables 
mammalian zinc transporters to perform 
moonlight functions beyond zinc transport. 
Finding interaction partners for a zinc 
transporter in a whole interactome setting may 
inform on its unconventional functions based 
on known cellular roles of the associated 
protein partners. 
 
A mass spectrometry-based discovery 
workflow was applied to profiling the ZIP6 
interactome followed by global interrogation of 
its in-cell functions using gene ontology (GO) 
enrichment analysis to assign putative cellular 
functions and associated processes. As 
described above, both ZIP6 and ZIP10 are 
critical players in EMT, but it is unknown which 
of the ZIP6 interactors links ZIP6 to the cell 
migratory machinery and how. The ZIP6 
interactome in mouse NMuMG cells was 
captured by anti-ZIP6 co-immunoprecipitation 
(co-IP) (136). Since the majority of proteins 
identified in co-IP experiments are non-
specific binders (137), specific ZIP6-binders 
are shortlisted based on the enrichment of 
bead-captured proteins derived from wild-type 
over ZIP6-KO cells (138). This quantitative 
proteomic analysis unequivocally identified 
ZIP10 as the strongest interactor of the ZIP6 
bait (136).  ZIP6 was found to interact with 
ZIP10 but not with other ZIP homologs, 
indicating an exclusive ZIP6-ZIP10 
heterodimeric assembly. Perturbation 
interactomes and corroborating biochemical 
analyses further demonstrated reciprocal 
effects of ZIP6 and ZIP10 on each other’s 
expression and coupled responses of ZIP6 
and ZIP10 expression to copper stimulation 
(136). ZIP6-ZIP10 heterodimerization 
appeared not to exclude homodimerization in 
distinct subcellular localizations, because 
17 
 
subcellular distributions of ZIP6 and ZIP10 
were only partially overlapping in 
neuroblastoma Neuro2a cells (136).  At 
present, the spatiotemporal dynamics of 
homo- and hetero-ZIP6 complexes remains to 
be elucidated. 
 
The second layer of the ZIP6 interactome 
appeared quite limited: only two additional 
strong ZIP6 binders were identified in the 
ZIP6-centric interactome datasets (136). 
These included calreticulin associated with the 
endoplasmic reticulum (ER)-resident protein 
folding machinery and the neural cell adhesion 
molecule 1 (NCAM1) (136). The latter 
prompted a second set of NCAM1-centric 
interactome analyses, establishing prominent 
interactions of NCAM1 with integrins, a well-
established hub protein in focal adhesion 
complexes that links intracellular actin bundles 
with the extracellular matrix (ECM) in many 
cell types to mediate cell anchoring, migration 
and ECM signaling (Fig. 3B). The overall ZIP6 
interactome was much smaller than the 
NCAM1 interactome, and comprised only 
relatively few interactors not shared by 
NCAM1 (136). A notable exception was 
glycogen synthase kinase 3 alpha (GSK3A) 
and beta (GSK3B) that formed exclusive 
interactions with ZIP6 (136). The hypothesis-
free co-IP proteomics data in combination with 
bioinformatics and experimental mappings of 
protein interactions and phosphorylation sites 
narrowed down the global interrogation of in-
cell ZIP6 functions to a putative protein hetero-
complex:   GSK3A/B-(ZIP6-ZIP10)-NCAM1-
focal adhesion complexes (Fig. 3B). This 
working model assumes that the (ZIP6-
ZIP10)-NCAM1 interactions may be mediated 
by self-templating heteromerization among 
PrP-like amino acid sequences within the 
ECDs of ZIP6, ZIP10 and the ECD of NCAM1, 
which was shown to bind PrP (139,140). The 
GSK3A/B-(ZIP6-ZIP10) interactions are 
mediated by a cytosolic His-rich loop that 
establishes a zinc sink at the exiting point of 
zinc influx as described above (64). Hence, 
the ZIP6-ZIP10 heterodimer may serve as a 
scaffold for binding and directing GSK3 
kinases to NCAM1 phospho-acceptor sites 
localized to a cytosolic domain in juxtaposition 
to the inner face of the plasma membrane. 
Phosphorylation of these sites was shown to 
be critical for NCAM1-mediated signaling in 
astrocytes (141). Since zinc is a highly specific 
inhibitor of GSK3 (142), an increase of the 
local zinc concentration by zinc transport 
through the ZIP6-ZIP10 heterodimer may 
inhibit the GSK3 activity in close proximity to a 
ZIP6 heterocomplex, thereby reducing the 
phospho-occupancy of NCAM1 sites and 
allowing its dissociation from focal adhesion 
complexes and the extracellular matrix (Fig. 
3B). Taken together, profiling ZIP6- and 
NCAM1-centric interactomes revealed 
intricate multi-component protein networking 
as an example to illustrate how mammalian 
zinc transporters are engaged in cellular 
protein machineries and localized to distinct 
subcellular locations. The positionings of 
specific zinc transporters in specific 
subcellular locations and protein complexes 
provide the molecular basis for precise 
controls of the local zinc concentration which 
would regulate diverse zinc-dependent 
cellular processes manifested in unique cell 
biology of specialized mammalian cells. In the 
following sections, we will discuss how some 
of the key mammalian zinc transporters are 
functionally integrated at the cellular level to 
regulate three important zinc-dependent 
cellular processes: zinc signaling, unfolded 
protein responses in the ER, and zinc 
ectoenzyme activation in the early secretory 
pathway. 
 
Cellular zinc signaling Zinc as a signaling 
molecule interacts with a multitude of 
intracellular or extracellular proteins and 
modulates their activities. While the 
extracellular zinc concentrations fluctuate with 
the dietary or serum zinc supplies, transient 
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changes in zinc extracellular concentrations 
can occur following release of zinc-containing 
vesicles from neurons, pancreatic β-cells and 
secretory cells of the intestine epithelium, 
mammary gland and salivary gland. ZnT3 
controls vesicular zinc concentrations in 
presynaptic cells (143), and the released 
neurosecretory zinc functions intercellularly as 
a neuromodulator of major post-synaptic 
channels, thereby modulating both excitatory 
and inhibitory post-synaptic responses (144). 
ZnT2 facilitates zinc accumulation into 
secretory granules of secreting intestinal and 
mammary epithelial cells (145,146). In 
epithelial cells, extracellular zinc regulates the 
activity of the store-operated calcium channel, 
forming a crosstalk between the extracellular 
zinc and intracellular calcium signaling (147). 
In pancreatic β-cells, ZnT8 is highly expressed 
in the insulin secretory vesicles (148,149), 
responsible for zinc enrichment to form zinc-
insulin hexamers for crystalline packaging 
(150). High glucose exposure stimulates 
insulin secretion while the co-secreted zinc 
ions act upon zinc-responsive membrane 
channels and receptors on the cell surface in 
a negative feedback loop to inhibit insulin 
secretion in both autocrine and paracrine 
fashions (151,152). The secreted zinc also 
acts as an endogenous molecular switch that 
increases insulin delivery to the peripheral 
target tissues by suppressing hepatic insulin 
degradation (153). These examples illustrate 
both short- and long-range signaling roles of 
extracellular zinc signaling in feedback 
controls of diverse cellular processes, in which 
zinc transporters regulate the pre-stimulation 
zinc loading in secretory vesicles, and activate 
post-stimulation clearance of the localized 
zinc concentration surge. However, what 
mediates extracellular zinc signaling is only 
partially understood. An orphan GPCR 
receptor belonging to the ghrelin/motilin 
receptor subfamily, GPR39, has been 
identified as a metabotropic zinc receptor 
(ZnR) (154,155). It was found to sense 
changes in the extracellular zinc level in 
pancreatic, gastrointestinal and neuronal 
tissues where zinc plays prominent 
physiological roles (156). GPR39 activities 
were described in neurons that are 
postsynaptic to vesicular zinc release and in 
pancreatic β-cells in which disruption of 
GPR39 impaired insulin secretion in vivo 
(157,158). At present, a functional link 
between GPR39 and mammalian zinc 
transporters is still unclear. This may be a key 
to understanding the mechanism by which 
zinc transporters regulate cellular responses 
to extracellular zinc fluctuations.   
 
Cytosolic zinc is thought to be an intracellular 
signal that relays external stimuli to 
intracellular responses via phosphorylation-
dephosphorylation (159). In this process, 
phosphate residues are transferred from one 
signaling molecule to the next in a consecutive 
cascade leading to gene expression in the 
nucleus. Phosphorylation and 
dephosphorylation are mediated by protein 
kinases and phosphatases, respectively. Their 
interplays regulate spatial and temporal signal 
processing of cell surface stimulations into two 
general categories of signaling outputs: a 
graded downstream response that provides 
feedback to restore cellular homeostasis, and 
a binary all-or-none response that pushes the 
cell out of homeostasis, driving cue-based 
decision-making on cell fates such as 
proliferation, differentiation and apoptosis 
(160). Zinc is an activator of diverse protein 
kinases (161-165), and also a reversible 
inhibitor of phosphatases at physiological 
concentrations (166). Hence, cytosolic zinc 
fluctuations could effectively switch on/off 
phosphor-transfer by synergizing the actions 
of zinc-dependent protein kinases and 
phosphatases. In living cells, basal levels of 
protein kinases and phosphatases undergo 
constant fluctuations due to stochasticity in 
gene expression (167). The dual controls of 
protein kinases and phosphatases by the 
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cytosolic zinc concentration make zinc 
transporters effective regulators in a role that 
damps out stochastic fluctuations in noisy 
phosphor-transferring cascades, thereby 
improving the fidelity of signal transduction. 
 
Mammalian ZIPs are emerging as important 
regulators of two modes of phosphor signaling 
by modulating a graded cytosolic zinc level as 
well as directly participating in positive 
feedback loops of the binary decision-making 
process.  Among mammalian ZIPs, ZIP7 is 
unique for its localization to the early secretory 
pathway including the ER (168,169). It 
functions as a zinc gatekeeper that tightly 
controls the movement of zinc from the ER 
zinc store into the cytosol and relies on 
phosphorylation to activate its zinc transport 
activity (113). In pancreatic β cells, ZIP7 is the 
most abundantly expressed among ZIP 
homologs (170), and its mRNA level is 
upregulated in response to glucose 
stimulation (171). Functionally, ZIP7 and the 
surface-expressed ZIP6 are mutually 
compensatory in β cells. Double knockdown of 
ZIP7 and ZIP6 significantly impaired the 
glucose-stimulated cytosolic zinc surge and 
insulin secretion (172), suggesting that both 
ZIP7 and ZIP6 play an important regulatory 
role in the phosphor transduction from a 
common extracellular glucose signal diverging 
to a cytosolic zinc surge and insulin secretion, 
which is primed in β-cells through activations 
of both PKC and PKA (173). Zinc is an 
activator of PKCs as a structural component of 
a conserved regulatory domain in all PKC 
isoforms (162). Zinc is also a potentiator of 
PKA by binding to a zinc-dependent 
phosphodiesterase to inhibit cAMP hydrolysis 
(174). The combined transport activities of 
ZIP6 and ZIP7 may activate PKCs and 
augment the PKA activity via a cytosolic zinc 
concentration increase (172,175), promoting 
glucose stimulated insulin secretion (GSIS). 
 
The molecular mechanism linking cell surface 
stimuli to cytosolic zinc surge and downstream 
responses was further examined in tamoxifen-
resistant MCF-7 breast cancer cells.  
Extracellular stimuli such as epidermal growth 
factor plus calcium ionophore elicited a 
transient protein association between protein 
kinase CK2 and ZIP7 within minutes (113). 
ZIP7 phosphorylation on two adjacent 
residues (S275 and S276) by CK2 triggered 
ZIP7-mediated zinc release from the ER into 
the cytosol where an elevated zinc level 
activated multiple downstream proliferative 
tyrosine kinase pathways, resulting in 
aggressive cell proliferation and enhanced 
migration (Fig. 4). Of note, CK2 is a zinc 
metalloenzyme containing a zinc finger that 
mediates dimerization interactions in a multi-
subunit CK2 complex (176), raising the 
possibility that zinc itself regulates CK2 activity 
to complete a feedback loop consisting of 
CK2-activation of ZIP7, gated zinc release and 
zinc-activation of CK2. As such, a positive 
feedback generates switches for zinc-
dependent protein kinases and phosphatases, 
converting graded phosphorylation responses 
to a binary cell fate decision on cancer cell 
proliferation and metastasis in response to 
environmental cues (Fig. 4).  
 
Tamoxifen-resistant MCF-7 breast cancer 
cells are characterized by higher endogenous 
levels of  both intracellular zinc and ZIP7, but 
not other ZIP homologs (108). This unusual 
cellular attribute suggests a prominent 
signaling role for ZIP7 as a gatekeeper of 
intracellularly stored zinc in these cells. 
Tamoxifen-resistant MCF-7 cells rely on the 
activation of tyrosine kinases such as EGFR, 
IGF1-R and Src (177), and the downstream 
activation of MAPK, PI3-K/AKT and mTOR 
pathways to aid their aggressive behavior 
(178), which are all driven by ZIP7-mediated 
zinc release from stores (179,180). Since ZIP7 
and CK2 are ubiquitously expressed, and the 
CK2 phosphorylation site in ZIP7 is highly 
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conserved in a wide range of different species 
(113,168), ZIP7 may function as a general 
CK2-mediated phosphorylation switch of zinc 
release from intracellular stores. In 
cardiomyocytes, high glucose exposure 
upregulated ZIP7 expression and induced its 
phosphorylation to trigger zinc release, 
resulting in a redistribution of the cellular zinc 
between the sarco(endo)plasmic reticulum 
and cytosol (181). In this process, ZIP7 
phosphorylation was mediated by CK2, which 
in turn was upregulated by both high glucose 
exposure and elevated cytosolic zinc 
concentrations, contributing in a positive 
feedback cycle to further zinc release in 
response to glucose stimulation (181). In 
human osteosarcoma MG-63 cells (182), 
genetic ablation of ZIP7 resulted in a 
decreased cytosolic zinc level accompanied 
by an increased ER zinc concentration. 
Although ZIP7 deletion induced upregulation 
of other zinc transporters, these changes were 
not sufficient to compensate for the loss of 
ZIP7, suggesting that ZIP7 is obligatory for 
cytosolic zinc homeostasis and signaling 
(182).  
 
The phosphorylation sites of ZIP7 were 
mapped to serine residues localized to  the 
cytoplasmic loop between TM3 and TM4 
(183). Among other ZIPs, ZIP6 and ZIP10 
have the greatest number of 19 and 20 Ser 
residues, respectively. A wide variety of 
kinases including CK2 are predicted to 
phosphorylate these sites. This observation 
raises the question of whether there is a link 
between ZIP7-mediated store release of zinc 
and the ability of plasma membrane located 
ZIPs to influx zinc from outside the cell (Fig. 
4). Additionally, there are few but noticeable 
predicted tyrosine phosphorylation sites in 
ZIP6, ZIP10 and ZIP14. ZIP7-mediated zinc 
release from zinc stores primarily inhibits 
tyrosine phosphatases, contributing to a shift 
of the phosphorylation-dephosphorylation 
balance toward more phosphorylated forms of 
ZIP6, ZIP10 and ZIP14. This could potentially 
activate these ZIPs in the surface membrane 
to bring in more zinc from the extracellular 
medium (Fig. 4). Another kinase with 
numerous predicted sites in ZIPs is GSK3, 
known to be inhibited by zinc (142). It is 
tempting to speculate that a possible GSK3-
ZIP interaction is mediated by a cytosolic His-
rich loop as described above (64). The 
proximity of this loop to the exiting point of zinc 
influx may raise the local zinc concentration to 
inhibit GSK3, thus providing a negative 
feedback control over zinc transport (80,184) 
(Fig. 4). Since ZIP7 has no predicted GSK3 
site, the zinc-mediated feedback control may 
be principally applicable to ZIPs in the surface 
membrane, particularly to ZIP6 and ZIP10 that 
contain a zinc sink as suggested by the largest 
numbers of His-residues in their cytosolic 
loops (Fig. 3A). 
 
In B-lymphocytes, a normal transport activity 
of ZIP7 is essential for the progression of 
sequential cellular transitions through quality 
control checkpoints in an orderly 
differentiation program (185). Multiple 
development stages are defined by the 
recombination status of immunoglobin loci in 
combination with the expression of cell 
surface markers (186). Progression of 
developing B-cells requires sequential 
integration of multiple signals determined by 
activities of protein kinases and 
phosphatases. The formation of the pre-B cell 
receptor constitutes the first major checkpoint 
of B-cell development. Hypomorphic 
mutations of ZIP7 caused a diminished 
cytosolic zinc concentration, increased 
phosphatase activity and decreased 
phosphorylation of signaling molecules 
downstream of the pre-B and/or B cell receptor 
signaling that impacted the differentiation 
decision on developing B-cells (185). 
Importantly, deficiency of ZIP7 alone among 
many ubiquitously expressed zinc 
transporters is sufficient to block B cell 
21 
 
development at the pre-B cell stage (185).  
These findings highlight a critical role of ZIP7 
as a gatekeeper of intracellularly stored zinc in 
modulating the B cell receptor signal strength 
that drives a positive selection of developing 
B-cells. 
 
While the phosphor-gated transport activity of 
the ER-residing ZIP7 is required for cell 
proliferation, differentiation and normal ER 
function (182),  the ZIP6-ZIP10 heterodimer in 
the surface membrane may also contribute to 
regulation of the cytosolic zinc level 
associated with cell division, especially during 
G2 and progression to mitosis (187,188). The 
essential role of extracellular zinc in cell 
proliferation was suggested by the ability of 
zinc to reverse a zinc chelation-induced 
suppression of cell cycle progression (189). 
When the cell was ready to progress into 
mitosis, ZIP6-ZIP10 heterodimer was 
upregulated on the plasma membrane to 
increase zinc influx to specifically activate the 
normal processes of mitosis such as 
microtubule reorganization and chromosome 
condensation (130). This mechanism was 
demonstrated in part by the correlation 
between antibody inhibition of ZIP6 or ZIP10 
and the pause of mitotic initiation, even in the 
presence of mitotic inducers such as 
nocodazole (130). These anti-ZIP antibodies 
are directed to the extracellular epitopes. 
Antibody binding may physically prevent zinc 
access or prevent access of proteases to 
cleave the N-terminal regions, which are 
required to activate zinc transport. Taken 
together, accumulating data suggests 
concerted actions of ZIP6-ZIP10 and ZIP7 in 
the regulation of cytosolic zinc influxes from 
both the extracellular medium and intracellular 
store to control cytosolic signaling via zinc-
dependent phosphorylation and 
dephosphorylation processes. 
 
Regulations of ER homeostasis and 
unfolded protein response The ER is a 
major intracellular zinc store of mobilizable 
zinc ions that could be released in response to 
extracellular stimuli as described above (190). 
The luminal free zinc concentration was 
estimated to be over 5 nM by an ER-targeted 
genetically-encoded zinc probe, suggesting a 
large and outwardly orientated zinc 
concentration gradient across the ER 
membrane (191). Zinc storage in the ER 
lumen depends on the buffering capacity of a 
wealth of nascent zinc binding proteins and 
the abundant luminal resident chaperone 
protein calreticulin, which binds zinc and 
calcium independently as a multifunctional 
metal ion sink (192). Interestingly, the major 
ER zinc-releasing transporter ZIP7 contains a 
His-rich luminal domain which may hold on 
zinc ions and release them into the cytoplasm 
when activated by phosphorylation (Fig. 4). 
The ER is also a major organelle responsible 
for protein folding, maturation, quality control 
and trafficking (193). When the ER becomes 
stressed due to an accumulation of newly 
synthesized unfolded proteins, the unfolded 
protein response (UPR) is activated to re-
establish normal ER homeostasis. In case of 
severe and unresolved ER stress, a persistent 
activation of the UPR triggers apoptosis (194). 
Zinc is a structural component of many 
metalloproteins. A lack of zinc when used as a 
cofactor can adversely affect the metalation of 
ER-resident proteins, thereby affecting their 
correct folding and functions. Zinc deficiency 
in the ER is sensed by the copper zinc 
superoxide dismutase (SOD1) as a molecular 
switch for initiating the zinc-dependent UPR 
(195). Conversely, excess zinc could bind 
promiscuously in competition against other 
essential metal ions, yielding misfolded or 
non-functional metalloproteins. Hence, a flux 
balance between zinc and the nascent 
unfolded polypeptides is necessary for proper 
ER functions. As the ER protein burden 
fluctuates with varying metabolic demands, 
ER-resident zinc transporters regulate the 
transmembrane zinc influx to keep pace with 
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changes in the influx of nascent unfolded 
polypeptides. Among cellular zinc 
transporters, ZnT5, ZnT6, and ZnT7 are 
ubiquitously expressed and probably involved 
in zinc supply into the ER (114,118,120) 
whereas ZIP7 is a major gate-keeper of zinc 
release from the ER into the cytosol (113). The 
coordinated actions of ZnTs and ZIPs regulate 
zinc redistribution between the cytosol and the 
ER lumen, as such, ER-resident zinc 
transporters are functional bridges linking the 
ER zinc load and the protein folding capacity 
with the cytosolic zinc concentration and zinc 
signaling.  
 
In an oxidizing environment of ER lumen, free 
thiols are not available to provide high-affinity 
zinc buffering capacity. Fluctuations of the ER 
zinc concentration with varying cellular 
metabolic demands may evoke a rapid control 
over the net zinc flux into or out of the ER 
lumen. ZIP7 ablation in MG-63 osteosarcoma 
cells was shown to increase protein disulfide 
isomerase-A1 (PDI), involved in oxidative 
folding, and activate the transcription factor 
C/EBP homologous protein (CHOP) whose 
target genes increase the ER client protein 
load and oxidation (196). CHOP activation 
following the UPR is a hallmark of 
maladaptation against ER stress that 
sensitizes cells to ER-stress induced 
apoptosis (197). On the other hand, ZIP7 
overexpression reduced ER stress with a 
significant reduction in CHOP and PDI (182). 
Mice lacking ZIP7 in the intestinal epithelium 
triggered ER stress in proliferative progenitor 
cells with a significant increase of apoptotic 
cell death (198). In human KBM7 myeloid 
leukemia cells, loss of ZIP7 resulted in 
augmented ER stress and impaired TNF 
receptor trafficking to the surface membrane 
(199). Emerging data suggests a general 
protective role of ZIP7 against ER-stress. In 
addition, the surface-expressed ZIP14 was 
shown to be critical for adaptation to ER stress 
(200). During ER stress, the UPR-activated 
transcription factors ATF4 and ATF6α up-
regulated ZIP14 expression leading to hepatic 
zinc uptake. The resultant cytosolic zinc 
increase was proposed to inhibit protein-
tyrosine phosphatase 1B (PTP1B) activity, 
which acts to suppress apoptosis and 
steatosis associated with hepatic ER stress. 
Likewise in human EndoC-βH1 pancreatic β 
cells, cytokine-induced ER stress also 
significantly upregulated both ZIP7 and ZIP14 
expression (170), consistent with protective 
roles of  both ZIP7 and ZIP14 in promoting 
adaptive UPRs in diverse mammalian cell 
types.  
 
The requirement of zinc transporters for 
normal ER functions appears conserved 
among eukaryotes. A yeast zinc transporter 
MSC2 is ER-resident and acts as a zinc-
sequestrating transporter that delivers 
cytosolic zinc to the ER lumen. MSC2 is a 
homolog of mammalian ZnT5 and its zinc-
limited mutants exhibits UPR activation and 
defective ER-associated protein degradation 
(119). In chicken DT40 lymphoma cells, 
double deletions of ZnT5 and ZnT7 induced 
UPR due to defective zinc sequestration into 
the ER lumen (118), suggesting that both 
excess and deficiency of zinc in the ER could 
induce ER stress. This is further evidence of 
how multiple ZnTs and ZIPs work in concert to 
regulate the balance of ER zinc sequestration 
and release. Factors that induce ER stress 
might be alleviated by compensatory 
regulations of zinc transporter expression and 
function whereas maladaptation of zinc 
transporters exacerbates ER stress and 
apoptosis.  
 
The coordinated actions of ZnTs and ZIPs in 
promoting adaptive UPR are further illustrated 
in the pancreatic β cells, which are 
professional insulin-producing secretory cells 
that naturally undergo high levels of ER stress 
as a result of normal secretory physiology 
(201).  About 50% of biosynthetic capacity in 
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pancreatic β-cells is dedicate to insulin 
production upon glucose stimulation (202). 
Glucose stimulation could boost the 
translation of preproinsulin by ~50-fold, 
flooding the ER lumen with nascent peptide 
chains for folding and the formation of three 
disulfide bonds per insulin molecule (194). 
The synthesized insulins are complexed with 
zinc to form zinc-insulin crystals for storage in 
insulin secretory granules (ISGs), yielding one 
of the highest quantities of cellular zinc in the 
human body (11,203). ZnT8 is a major zinc 
sequestrating transporter responsible for zinc 
enrichment in ISGs (148,149) and insulin 
packaging (150,204-207). Accordingly, ZnT8 
expression in β-cells is over 10 times more 
abundant than other zinc transporters at the 
mRNA level (208,209), and its protein level in 
EndoC-βH1 cells is compatible to that of the 
housekeeping α-tubulin (170). Importantly, the 
subcellular localizations of ZnT8 have an even 
distribution between the ER and ISGs, 
contributing significantly to both zinc loading 
and protein folding in the ER (170).  
 
Surprisingly, the ZnT8 protein level in human 
EndoC-βH1 cells remained unchanged in the 
face of large fluctuations of insulin synthesis 
and secretion upon physiological glucose 
stimulations (170). In contrast, a trace amount 
of proinflammatory cytokines triggered a rapid, 
graded and reversible degradation of ER-
resident ZnT8 while the ISG-resident ZnT8 
remained largely unchanged (170). These 
findings demonstrated exquisite specificity of 
ER-resident ZnT8 to cytokine stimulations.  
Transcriptome profiling of cytokine-exposed β 
cells revealed an adaptive UPR including a 
marked immunoproteasome activation that 
degraded ZnT8 and insulin coordinately over 
a 1000-fold cytokine concentration range. 
Apparently, the cytokine signaling pathways 
leading to ZnT8 and insulin degradation are 
highly intertwined and intersected at a shared 
ubiquitin proteasome system, highlighting the 
importance of ZnT8 and insulin decongestion 
in restoring ER homeostasis under 
inflammatory insult (170). Among all ZnTs and 
ZIPs, ZIP7 is the second highest transcribed 
gene after ZnT8 in EndoC-βH1 cells. The 
reduction of ZnT8 transcript was functionally 
synergetic with an increase of ZIP7 because 
ZnT8 and ZIP7 transport zinc in opposite 
directions across the ER membrane 
(210,211). In this way, the net zinc influx is 
reduced to compensate for a reduction of 
insulin biosynthesis under cytokine-induced 
ER stress, demonstrating how ER-resident 
zinc transporters may be coupled with the 
burden of protein processing to promote ER 
adaptation to stress conditions (212). 
 
Activation and trafficking of zinc 
ectoenzymes in the early secretory 
pathway Approximately one-third of all 
cellular proteins encounter the secretory 
pathway (213). In yeast, up to 14% of zinc 
proteins are localized to organelles or 
extracellularly secreted (214,215). If this is 
applied to mammalian cells, more than 4% of 
total proteins are sorted to be loaded with zinc 
in the ER and then the Golgi apparatus. 
Among these proteins, a considerable 
proportion is thought to constitute zinc 
ectoenzymes including compartment-
resident, membrane-bound, and secretory 
zinc metalloenzymes. They capture zinc for 
maturity within the early secretory pathway 
before trafficking to their final destinations. 
Loss of zinc in these enzymes could 
potentially result in misfolding or failure to 
acquire the proper post-translational 
modifications, which would be another trigger 
of ER stress (118,119). Zinc metalation in the 
early secretory pathway is indispensable for 
some ectoenzymes, because their reduced 
activities in zinc-deficient cells were not 
recoverable by a later addition of excess zinc 
(216). Hence, zinc transport into the early 
secretory pathway is sophisticatedly 
maintained from the perspective of functional 




As described above, ZnT5, ZnT6, and ZnT7 
constitute zinc supplying routes to nascent 
ectoenzymes in the early secretory pathway 
(114,118,217). ZnT5-ZnT6 heterodimers and 
ZnT7 homodimers contribute to the activation 
of a number of specific zinc ectoenzymes 
including ALPs, Ecto-5’-nucleotidase, and 
Autotaxin (ATX, which is also called 
ectonucleotide 
pyrophosphatase/phosphodiesterase 2, 
ENPP2) (218,219). However, some 
ectoenzymes can coordinate zinc at their 
active site independently of both ZnT dimers 
(101,216). Different motif/sequences required 
for activations of ZnT-dependent 
ectoenzymes have been identified in 
mammalian ZnTs and their targeting 
ectoenzymes. The former example is a unique 
Pro-Pro (PP) motif present in a luminal 
(extracellularly) loop between TM3 and TM4 of 
ZnT5 (actually TM12 and TM13 of ZnT5, 
because its long N-terminal portion contains 
extra 9 TMs) and ZnT7, which are highly 
conserved among their yeast and plants 
orthologs. Substitution of PP with AA 
significantly reduced ALP activation without 
affecting their zinc transport activity (220). 
However, contribution of the PP motif to 
enzyme activation is less clear in ATX/ENPP2 
activation (219), suggesting that certain 
differences exist in the metalation process of 
different ectoenzymes. Complementary 
motif/sequences required for ZnT-dependent 
ectoenzyme activation was identified by a 
domain swapping between ATX/ENPP2 and 
its homolog ENPP3. Both ATX/ENPP2 and 
ENPP3 require zinc for activity, but their 
dependency on ZnTs is completely different: 
the lysophospholipase D activity of 
ATX/ENPP2 is ZnT-dependent, whereas the 
adenine nucleotide hydrolysis activity of 
ENPP3 does not need ZnT-activation. Crystal 
structures revealed several characteristic 
differences among members of the enzyme 
family (221). Uniquely, ATX/ENPP2 lacks a 
characteristic insertion loop (IL), yet has four 
residue substitutions in the catalytic domain as 
compared with ENPP3. The substitution 
mutations of ATX/ENPP2 resulted in the gain 
of adenine nucleotide hydrolysis activity but a 
loss of the ZnT-dependency (216). Thus, a 
fine-tuned zinc metalation mechanism may be 
explained based on small structural difference 
on the protein surface, presumably involved in 
protein interactions. 
 
Some zinc ectoenzymes cannot stably exist in 
an apo-form in cells lacking both ZnT5-6 and 
ZnT7 dimers, indicating that they are also 
closely associated with protein quality control 
of ectoenzymes. The representative examples 
include degradation of ALPs through ubiquitin-
proteasomal and lysosomal degradation 
pathways in ZnT5, ZnT6 and ZnT7 triple 
deficiency cells.  This degradative process is 
irreversible even if excess zinc is added to the 
cell culture (124,218). ZnT5 transcription is 
induced by ER stress through a transcription 
factor XBP-1 in HeLa cells, mouse ES cells 
and mouse MIN6 pancreatic β cells (118), 
which is consistent with the notion that ZnT5-
6 and ZnT7 contribute to protein quality control 
in the early secretory pathway as described 
above. The abilities of ZnT5-6 and ZnT7 to 
stabilize ALPs may be independent of zinc 
transport activity, because their transport-null 
mutants blocked the degradation of ALPs and 
enabled ALPs to be present as an apo-form 
(218). However, this may be cell-type specific 
(124). The deletion of the C-terminal 
glycosylphosphatidylinositol (GPI) anchor, 
which is attached to the carboxyl terminus of 
ALPs, made ALPs stabilized in cells lacking 
both ZnT5-6 and ZnT7(124). Thus, post-
translational modifications may also contribute 
to ZnT-dependent stability of ALPs. Further 
investigation is required to elucidate the 
molecular mechanisms by which ZnT5-6 and 
ZnT7 regulate the relationship between 
activity and stability/degradation of zinc 
ectoenzymes. Understanding quality control 
25 
 
mechanism of zinc ectoenzymes is of 
pathophysiological importance, because 
many zinc ectoenzymes are associated with 
cell fate and activity (213,222). 
 
ZnT5-6 and ZnT7 also supply zinc to zinc 
proteins other than zinc ectoenzymes. One of 
them is the ER chaperone ERp44. Its C-
terminal conformation is responsive to zinc 
binding (223). This zinc dependent 
conformational change exposes its substrate-
binding surface and the ER retention/retrieval 
RDEL motif, which drives ER-Golgi retrograde 
transport of ERp44 accompanied by the 
capture and retrieval of client proteins such as 
Ero1α and ERAP1. Although Ero1α and 
ERAP1 are non-zinc proteins, zinc binding to 
ERp44 is crucial for their functions in disulfide 
bond formation, processing and trafficking of 
secreted and cell-surface proteins in the ER. 
Moreover, ZIP7 and possibly other ZIP 
homologs play pivotal roles in zinc 
homeostatic control in the ER as described 
above (198,224). Intriguingly, both loss and 
gain of expression of these ZIPs cause no 
significant effects on stability/degradation of 
zinc ectoenzymes, arguing against a direct 
involvement of these mammalian ZIPs in post-
translational modifications of ectoenzyme 
(124). Apparently, zinc supply to the early 
secretory pathway may require specific 
protein interactions to have a direct impact on 
the metalation and activation of certain zinc 
ectoenzymes.  
 
Zinc transporters and human diseases 
Clarification of the molecular functions of zinc 
transporters contributes to the understanding 
of their causal relationships with major human 
diseases. An extensive body of preclinical 
studies using knockout and transgenic animal 
models has been reviewed elsewhere 
(225,226). Here we overview human genetic 
findings associated with loss-of-function (LOF) 
mutations in human ZnTs and ZIPs, their 
clinical manifestations and potential 
mechanism of actions. Thus far, eight types of 
LOF mutations have been identified and linked 
to diverse human diseases such as 
neurodegeneration, immunodeficiency, 
cancer and diabetes. Among them, LOF 
mutations in human ZnT8 are unique for their 
protection against type-2 diabetes (T2D) 
(227,228). All LOF mutations in other human 
zinc transporters are of deleterious 
consequences, including zinc deficiencies 
known as acrodermatitis enteropathica (AE, 
LOF mutations in SLC39A4/ZIP4) (229,230) 
or transient neonatal zinc deficiency (TNZD, 
those in SLC30A2/ZnT2) (231-233), the 
skeletal and connective tissue disease named 
spondylocheiro dysplastic form of Ehlers–
Danlos syndrome (SCD-EDS, those in 
SLC39A13/ZIP13) (234,235), 
agammaglobulinemia (those in 
SLC39A7/ZIP7) (185), Parkinsonism (those in 
SLC30A10/ZnT10 or SLC39A14/ZIP14) (236-
238), and type II congenital disorders of 
glycosylation (CDG, those in SLC39A8/ZIP8) 
(239,240), although the last two diseases are 
thought to be associated with dysregulations 
of systemic and cellular manganese 
homeostasis (Fig. 1A).  
 
AE is featured by severe dermatitis caused by 
malabsorption of zinc in the duodenum and 
jejunum, attributed to the indispensability of 
ZIP4 in the process. TNZD is developed in 
infants exclusively breast-fed by mothers 
carrying LOF mutations in ZnT2, reflecting an 
essential role of ZnT2 in zinc secretion into the 
breast milk in mothers. SCD-EDS is featured 
by joint hypermobility, skin elasticity, and 
tissue fragility, and thus ZIP13 plays critical 
roles for the development of hard and 
connective tissues. Agammaglobulinemia is 
caused by LOF mutations in ZIP7, which is 
required for proper signaling via the B cell 
antigen receptor (BCR) in early B cell 
development as described above. Loss of 
functions of ZnT10 and ZIP14 develops 
manganese-induced Parkinsonism (241), 
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attributed to their synergistically biliary 
manganese excretion: ZIP14 plays a pivotal 
role in manganese uptake from blood into 
hepatocytes whereas ZnT10 have a 
significant role in manganese excretion into 
bile. In contrast, type II CDG is caused by 
manganese deficiency as a result of impaired 
ZIP8 activity in reclaiming manganese from 
bile. The molecular mechanisms underlying 
their manganese transport ability are 
suggested by amino acid differences in the 
putative metal-binding site within their 
transmembrane domains, specifically the zinc 
transport-site of ZnT10 (43,44), or the 
binuclear metal center in ZIP8 and ZIP14 
(242,243).  
 
In addition to pathogenetic LOF mutations, 
non-synonymous SNPs have been associated 
with diverse human diseases.  For example, 
rare polymorphic variants impair ZIP4 
cleavage, resulting in AE (72). An alanine to 
threonine change at position 391 of ZIP8 
resulted from a non-synonymous SNP 
(rs13107325 CT) in SLC39A8 is associated 
with a variety of diseases including Crohn's 
disease (244,245), severe Idiopathic Scoliosis 
(246), and circulating lipid levels and risk of 
coronary artery disease (247). Moreover, 
aberrant expressions of human zinc 
transporters are pathogenic. Alterations of 
ZnT expression have been associated with 
neurodegenerative diseases including 
Alzheimer’s disease (248) and amyotrophic 
lateral sclerosis (249). The representatives of 
ectopic expression are ZIP8 in cartilage 
tissue, which causes cartilage destruction 
(250), and ZIP4 in pancreatic cancer 
progression, which promotes tumor growth 
(251).  
Similar to ZIP4, a number of ZIPs are 
upregulated in various cancer cells 
(108,180,252,253). These often include LIV-1 
subfamily members which are present in 
increased amounts in breast cancer especially 
ZIP6 (86) and ZIP10 (252), which both 
encourage EMT and cell detachment involved 
in metastasis. ZIP7, known to be directly 
responsible for driving aggressive pathways 
such as AKT, MAPK and mTOR (178) is 
increased in anti-hormone resistant breast 
cancer (180). The antibody recognising 
phosphorylated ZIP7, the zinc-transporting 
form (113), is a reliable marker of aggressive 
cancer (254). ZIP7 is also associated with 
poor outcome in clinical breast cancer 
samples (255), consistent with a role in driving 
these aggressive growth pathways yet it has 
also been deemed crucial for enabling the 
survival of breast cancer patients (256). Since 
elevated cellular zinc levels generally 
encourage cells growth and proliferation, a 
growing variety of cancers has been 
associated with upregulations of multiple ZIPs. 
Among them, ZIP7 has been linked to gastric 
cancer by an ability to drive the AKT and 
mTOR pathways (257). ZIP8 is one of four 
genes linked to a risk of developing 
hepatocellular cancer (258). ZIP10 is one of 
four genes as a signature of poor survival in 
glioblastoma (259) and ZIP4 is increased in 
hepatocellular cancer (260) and likely to 
increase resistance to treatment in pancreatic 
cancer by preventing drug uptake (261). Many 
cancers are driven by tyrosine kinases and 
therefore it is not surprising that ZIPs, which 
generally increase intracellular zinc, are often 
implicated in increased growth of cancers by 
zinc-mediated inhibition of tyrosine 
phosphatases.  
SLC30A8, the gene encoding ZnT8, was one 
of the first T2D susceptibility loci identified by 
GWAS (262-264). A non-synonymous SNP in 
the SLC30A8/ZnT8 (rs13266634 CT), which 
causes an arginine to tryptophan change at 
position 325, is associated with increased risk 
of T2D (262). A major limitation of GWAS is its 
hypothesis-free approach that tests disease 
associations without assuming any gene 
function (265). The next breakthrough in 
human genetics of T2D was the identification 
of 12 SLC30A8 nonsense/frameshift (or LOF) 
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mutations that significantly protect against 
T2D (228). This large yet unexpected 
protective effect contradicted a perceived 
beneficial role of ZnT8 in insulin secretion 
(266). A causal relationship between ZnT8 
activity and T2D risk was established by 
comparing zinc transport activities of a pair of 
missense SNP variants (ZnT8-R325W) in 
reconstituted proteoliposomes (267). The 
higher-risk variant (R325) was found 
consistently more active than the lower-risk 
variant (W325), supporting the notion that 
reducing ZnT8 activity is beneficial for 
reducing T2D risk (267). The protective effect 
of a LOF allele p.Arg138* was associated with 
better insulin secretion due to enhanced 
glucose responsiveness and proinsulin 
conversion (268).  The p.Arg138* allele 
resulted in reduced ZnT8 expression in human 
induced pluripotent stem cell (iPSC)-derived β-like cells (268). About 50% of cellular ZnT8 
in human insulinoma EndoC-βH1 cells was 
localized to the ER where ER-associated 
ZnT8 degradation afforded protection against 
ER-stress induced by proinflammatory 
cytokines  (170). Similarly, down-regulation of 
the cellular ZnT8 level by LOF mutations may 
constitute a protective mechanism against 
inflammatory stress, a major pathogenic 
trigger of T2D (269,270).  Until now, over 150 
T2D-susceptibility loci have been identified, 
confirming the polygenic nature of T2D (271). 
Many different genetic events can interact 
together and with environmental factors (272). 
Only a few of these associated genetic 
variants are expected to be penetrant enough 
to cause T2D. A recent whole exome 
sequencing analysis identified SLC30A8 as 
one of the top four 4 genes that gave strongest 
T2D gene-level signals for rare variants, 
establishing ZnT8 as a top target of 
prioritization for drug discovery (227). 
 
Unmet research needs and perspectives 
Over the last decades, interdisciplinary 
research tools have been developed to 
explore structures, dynamics, subcellular 
localizations and protein interactions of 
individual zinc transporters, and quantitative 
proteomic studies have begun to elucidate 
how mammalian zinc transporters are 
integrated into protein networks. However, 
major knowledge gaps exist.  It is still unclear 
about the molecular determinant of metal 
selectivity and the precise transport 
mechanism of mammalian ZIPs. The 
hypothetical zinc-specific metallochaperones 
or other related zinc-trafficking proteins have 
yet to be identified to uncover the molecular 
mechanisms driving zinc transfer between 
individual zinc transporters and their 
respective zinc donor or acceptor proteins. 
The molecular identities of membrane bound 
APs have yet to be determined to understand 
their specific interactions with various ZnTs 
and ZIPs to shuttle between the cell surface 
membrane and intracellular compartments. 
Progresses in these aspects will bring clearer 
answers to the fundamental questions as to 
where, when and how zinc is delivered to 
specific protein targets and subcellular 
destinations in response to cellular stimuli. At 
the cellular level, a multitude of ZnTs and ZIPs 
work in concert to determine the localized zinc 
concentration dynamics that regulate zinc-
dependent cellular processes. The functional 
interplays and relative contributions of 
individual zinc transporters to the subcellular 
zinc distributions and dynamics need to be 
evaluated globally in the context of competing 
or compensatory zinc transporters and 
interacting protein partners. Finally, 
investigation into in-cell zinc transporter 
functions will be expanded to interrogation of 
zinc transporter interactomes. The 
identification of zinc-regulated functional 
components and their roles in protein 
networking will provide mechanistic insights 
into the functional consequences of gain- or 
loss-of-function mutations in zinc transporters 
and their impacts on critical cellular processes 




Existing knowledge of in-cell functions of 
mammalian zinc transporters is largely 
derived from phenotypic interrogations of 
gene deletion or over-expression of individual 
zinc transporters, but a genuine mutation-
function relationship may be distorted or even 
lost if functional compensations by other zinc 
transporters come into play and stochiometric 
protein interactions are a determinant factor of 
the phenotypic outcome. Recent advances in 
high-resolution mass spectrometry have 
enabled global profiling of zinc transporter 
interactomes by co-immunoprecipitation of 
endogenous zinc transporters in complex with 
their native interacting partners, but 
complementary tracking reagents and 
multiplex immunodetection methods are 
needed to validate proteomic findings by 
parallel in-cell measurements of endogenous 
zinc transporter levels, post-translational 
modifications (e.g. phosphorylation, 
ubiquitination and proteolytic cleavage), and 
protein-protein interactions in a multifactorial 
space of environmental stimuli over a dynamic 
concentration range, temporal scale and 
subcellular locations of pathophysiologic 
relevance. Accordingly, the in-cell zinc 
transport functions of individual zinc 
transporters will be examined in relevant 
mammalian cells as oppose to the test tube. 
Pathophysiological stimulations will be applied 
to perturb cellular hemostasis, and the 
dynamic process of zinc transporter 
responses will be monitored to infer their 
functional roles in restoring homeostasis. 
While transport activities of individual zinc 
transporters allow for fine controls of localized 
zinc concertation gradients in subcellular 
locations and even in specific protein 
complexes engaged in cellular processes, 
these cellular processes are also influenced 
by a myriad of zinc-independent signals and 
protein interactions. As such, a 
pathophysiological stimulation to the cell 
surface receptor could propagate along 
parallel signaling cascades and spread 
through extensive protein networks to yield a 
complement of input-output relationships, only 
a fraction of which is dictated or regulated by 
zinc transporters. These input-output 
relationships could be monitored in parallel 
and described in measurable parameters such 
as stimulation-dependent endogenous protein 
levels or pairwise protein-protein interactions. 
Large datasets will be parameterized and fed 
to machine learning algorithms to unravel 
inherent inter-parameter couplings that 
describe functional integrations of individual 
zinc transporters into cellular processes in a 
quantitative and predictable manner. A data-
intensive functional description of zinc 
transporters in native cellular environments 
represents a paradigm shift from descriptive to 
quantitative biology of mammalian zinc 
transporters.
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Fig. 1 Two complementary families of mammalian zinc transporters. A. Subcellular 
localization of ZIP (light pink) and ZnT (light blue) that are generally thought to be zinc-specific 
transporters. ZIP8 and ZIP14 (gold), and ZnT10 (pale green) transport manganese in addition to 
zinc. B, Phylogenetic trees of ZnT (upper) and ZIP (lower), C. Sequence alignments of key 
coordinating residues in the transport sites in bacterial YiiP (upper) and ZIPB (lower). Light coral 
shading highlights conserved His residues. Light blue shading highlights conserved Asp and Glu 
residues. His and Asp residues are reversed in TM4 of ZIP13. Pale turquoise shading highlights 
the conserved Cys residue in cell surface located LIV-1 family members of ZIPs that have been 
postulated to bind to the N-terminal CPALLY motif. Light green shading highlights loss of the 





Fig. 2 Structural basis for zinc selectivity and mobility A. Crystal structure of YiiP and close-
up views of zinc binding sites in TMD (upper) and at the CTD interface (lower). Red arrows 
indicate directions of zinc transport. TMs and coordinating residues are labeled. B. Crystal 
structure of ZIPB and close-up views of the binuclear metal center with a Zn and Cd ion (upper), 
and two Cd ions (lower) C. Schematic model depicting zinc-for-proton exchange in YiiP. ΔΦ 
denotes the membrane potential. The tetrahedral transport site in YiiP is formed by D45, D57, 
H153 and D157. The conserved L152 is a part of a hydrophobic gate between two solvent-filled 





Fig. 3 ZIP-centric interactome A. Topological structures of ZIPs with increased His-abundance 
in ZIP6 and ZIP10. His residues in the N-terminus, extracellular loop TM2-3 and intracellular loop 
TM3-4 are shown in light green with those greater than 20 are highlighted in light pink. TMs are 
numbered 1 to 8. The CPALLY motif and the PEST cleavage sites are indicated. Note, conserved 
His residues in TM2 and TM5 of ZIP14 and ZIP8 are replaced with Q and E, respectively. B. Zinc-
mediated disassembly of focal adhesion complexes. Cell attachment is provided by NCAM1 
binding to integrin which is attached to the extracellular matrix and tubulin bundle when the 
integrin is phosphorylated by the active form of GSK3. During EMT, a ZIP6-ZIP10 heterodimer in 
the focal adhesion complex promotes zinc influx which is captured by the cytosolic His-rich loop 
between TM3 and TM4 of ZIP6 and ZIP10. An increase of the local zinc concentration inhibits 
GSK3 (lighter blue), resulting in reduced NCAM1 phosphorylation. A reduced phospho-
occupancy of NCAM1 sites promotes integrin disassociation from the NCAM1-bound focal 
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adhesion complex, triggering cell detachment. PrP denotes prion protein domain. 14-3-3 proteins 
are proposed to engage the NCAM1-integrin interaction. 
 
 
Fig. 4 Zinc regulation of receptor signaling Zinc is an activator of diverse protein kinases 
(PKs), and also a reversible inhibitor of tyrosine phosphatases (TPs). The dual controls of PKs 
and TPs by the cytosolic zinc concentration improves the fidelity of signal transduction in a 
phosphorylation cascade leading to transcription factor activation and gene expression. CK2 
activates ZIP7 by phosphorylation at Ser residues in the cytosolic His-rich loop, triggering zinc 
release from the ER store. The increased local zinc concentration up-regulates the CK2 activity 
in a positive feedback loop of ZIP7 activation. Likewise, zinc dependent PKs, CK2 and GSK3 
may activate ZIPs in the plasma membrane to increase zinc influx. Increased local zinc 
concentrations activate CK2, but inhibit GSK3 to regulate zinc influx in a positive and negative 
feedback loop, respectively. An increase of the cytosolic zinc concentration could inhibit TPs to 
shift the balance of ZIP activity to a more activated (phosphorylated) form to augment zinc influx. 
The depleted ER zinc store may be replenished by joint actions of ZIPs on the cell surface and 
ZnTs in the ER. A putative zinc metallochaperone is proposed to shuttle cytosolic zinc from ZIP 
to ZnT to maintain a low cytosolic zinc concentration. 
